<?xml version="1.0" encoding="utf-8"?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2003-10-31" modified="2020-08-12" version="191">
<accession>Q8IXJ6</accession>
<accession>A8K3V1</accession>
<accession>B2RB45</accession>
<accession>O95889</accession>
<accession>Q924Y7</accession>
<accession>Q9P0G8</accession>
<accession>Q9UNT0</accession>
<accession>Q9Y6E9</accession>
<accession>U5TP13</accession>
<name>SIR2_HUMAN</name>
<protein>
<recommendedName>
<fullName>NAD-dependent protein deacetylase sirtuin-2</fullName>
<ecNumber evidence="20 21 26 35 52 56 57">2.3.1.286</ecNumber>
</recommendedName>
<alternativeName>
<fullName>Regulatory protein SIR2 homolog 2</fullName>
</alternativeName>
<alternativeName>
<fullName>SIR2-like protein 2</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">SIRT2</name>
<name type="synonym">SIR2L</name>
<name type="synonym">SIR2L2</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="1999" name="Biochem. Biophys. Res. Commun." volume="260" first="273" last="279">
<title>Characterization of five human cDNAs with homology to the yeast SIR2 gene: Sir2-like proteins (sirtuins) metabolize NAD and may have protein ADP-ribosyltransferase activity.</title>
<authorList>
<person name="Frye R.A."/>
</authorList>
<dbReference type="PubMed" id="10381378"/>
<dbReference type="DOI" id="10.1006/bbrc.1999.0897"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1)</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>MUTAGENESIS OF HIS-187</scope>
<source>
<tissue>Testis</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="1999" name="Gene" volume="234" first="161" last="168">
<title>Characterization of a human gene with sequence homology to Saccharomyces cerevisiae SIR2.</title>
<authorList>
<person name="Afshar G."/>
<person name="Murnane J.P."/>
</authorList>
<dbReference type="PubMed" id="10393250"/>
<dbReference type="DOI" id="10.1016/s0378-1119(99)00162-6"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2002" name="J. Neurochem." volume="81" first="575" last="588">
<title>A novel seven transmembrane receptor induced during the early steps of astrocyte differentiation identified by differential expression.</title>
<authorList>
<person name="De Smet C."/>
<person name="Nishimori H."/>
<person name="Furnari F.B."/>
<person name="Boegler O."/>
<person name="Huang H.-J.S."/>
<person name="Cavenee W.K."/>
</authorList>
<dbReference type="PubMed" id="12065666"/>
<dbReference type="DOI" id="10.1046/j.1471-4159.2002.00847.x"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2)</scope>
</reference>
<reference key="4">
<citation type="journal article" date="2014" name="J. Mol. Biol." volume="426" first="1677" last="1691">
<title>Constitutive nuclear localization of an alternatively spliced sirtuin-2 isoform.</title>
<authorList>
<person name="Rack J.G."/>
<person name="Vanlinden M.R."/>
<person name="Lutter T."/>
<person name="Aasland R."/>
<person name="Ziegler M."/>
</authorList>
<dbReference type="PubMed" id="24177535"/>
<dbReference type="DOI" id="10.1016/j.jmb.2013.10.027"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5)</scope>
<scope>ALTERNATIVE SPLICING (ISOFORMS 1 AND 2)</scope>
<scope>FUNCTION IN DEACETYLATION (ISOFORMS 1 AND 2)</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>LACK OF DEACETYLATION (ISOFORM 5)</scope>
<scope>INTERACTION WITH EP300 (ISOFORMS 1; 2 AND 5)</scope>
<scope>SUBCELLULAR LOCATION (ISOFORMS 1; 2 AND 5)</scope>
</reference>
<reference key="5">
<citation type="submission" date="2002-08" db="EMBL/GenBank/DDBJ databases">
<title>Response of autologous T cells to a human melanoma is dominated by individual mutant antigens.</title>
<authorList>
<person name="Lennerz V."/>
<person name="Fatho M."/>
<person name="Gentilini C."/>
<person name="Lifke A."/>
<person name="Woelfel C."/>
<person name="Woelfel T."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3)</scope>
</reference>
<reference key="6">
<citation type="journal article" date="2000" name="Proc. Natl. Acad. Sci. U.S.A." volume="97" first="9543" last="9548">
<title>Gene expression profiling in the human hypothalamus-pituitary-adrenal axis and full-length cDNA cloning.</title>
<authorList>
<person name="Hu R.-M."/>
<person name="Han Z.-G."/>
<person name="Song H.-D."/>
<person name="Peng Y.-D."/>
<person name="Huang Q.-H."/>
<person name="Ren S.-X."/>
<person name="Gu Y.-J."/>
<person name="Huang C.-H."/>
<person name="Li Y.-B."/>
<person name="Jiang C.-L."/>
<person name="Fu G."/>
<person name="Zhang Q.-H."/>
<person name="Gu B.-W."/>
<person name="Dai M."/>
<person name="Mao Y.-F."/>
<person name="Gao G.-F."/>
<person name="Rong R."/>
<person name="Ye M."/>
<person name="Zhou J."/>
<person name="Xu S.-H."/>
<person name="Gu J."/>
<person name="Shi J.-X."/>
<person name="Jin W.-R."/>
<person name="Zhang C.-K."/>
<person name="Wu T.-M."/>
<person name="Huang G.-Y."/>
<person name="Chen Z."/>
<person name="Chen M.-D."/>
<person name="Chen J.-L."/>
</authorList>
<dbReference type="PubMed" id="10931946"/>
<dbReference type="DOI" id="10.1073/pnas.160270997"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
<source>
<tissue>Adrenal gland</tissue>
</source>
</reference>
<reference key="7">
<citation type="journal article" date="2004" name="Nat. Genet." volume="36" first="40" last="45">
<title>Complete sequencing and characterization of 21,243 full-length human cDNAs.</title>
<authorList>
<person name="Ota T."/>
<person name="Suzuki Y."/>
<person name="Nishikawa T."/>
<person name="Otsuki T."/>
<person name="Sugiyama T."/>
<person name="Irie R."/>
<person name="Wakamatsu A."/>
<person name="Hayashi K."/>
<person name="Sato H."/>
<person name="Nagai K."/>
<person name="Kimura K."/>
<person name="Makita H."/>
<person name="Sekine M."/>
<person name="Obayashi M."/>
<person name="Nishi T."/>
<person name="Shibahara T."/>
<person name="Tanaka T."/>
<person name="Ishii S."/>
<person name="Yamamoto J."/>
<person name="Saito K."/>
<person name="Kawai Y."/>
<person name="Isono Y."/>
<person name="Nakamura Y."/>
<person name="Nagahari K."/>
<person name="Murakami K."/>
<person name="Yasuda T."/>
<person name="Iwayanagi T."/>
<person name="Wagatsuma M."/>
<person name="Shiratori A."/>
<person name="Sudo H."/>
<person name="Hosoiri T."/>
<person name="Kaku Y."/>
<person name="Kodaira H."/>
<person name="Kondo H."/>
<person name="Sugawara M."/>
<person name="Takahashi M."/>
<person name="Kanda K."/>
<person name="Yokoi T."/>
<person name="Furuya T."/>
<person name="Kikkawa E."/>
<person name="Omura Y."/>
<person name="Abe K."/>
<person name="Kamihara K."/>
<person name="Katsuta N."/>
<person name="Sato K."/>
<person name="Tanikawa M."/>
<person name="Yamazaki M."/>
<person name="Ninomiya K."/>
<person name="Ishibashi T."/>
<person name="Yamashita H."/>
<person name="Murakawa K."/>
<person name="Fujimori K."/>
<person name="Tanai H."/>
<person name="Kimata M."/>
<person name="Watanabe M."/>
<person name="Hiraoka S."/>
<person name="Chiba Y."/>
<person name="Ishida S."/>
<person name="Ono Y."/>
<person name="Takiguchi S."/>
<person name="Watanabe S."/>
<person name="Yosida M."/>
<person name="Hotuta T."/>
<person name="Kusano J."/>
<person name="Kanehori K."/>
<person name="Takahashi-Fujii A."/>
<person name="Hara H."/>
<person name="Tanase T.-O."/>
<person name="Nomura Y."/>
<person name="Togiya S."/>
<person name="Komai F."/>
<person name="Hara R."/>
<person name="Takeuchi K."/>
<person name="Arita M."/>
<person name="Imose N."/>
<person name="Musashino K."/>
<person name="Yuuki H."/>
<person name="Oshima A."/>
<person name="Sasaki N."/>
<person name="Aotsuka S."/>
<person name="Yoshikawa Y."/>
<person name="Matsunawa H."/>
<person name="Ichihara T."/>
<person name="Shiohata N."/>
<person name="Sano S."/>
<person name="Moriya S."/>
<person name="Momiyama H."/>
<person name="Satoh N."/>
<person name="Takami S."/>
<person name="Terashima Y."/>
<person name="Suzuki O."/>
<person name="Nakagawa S."/>
<person name="Senoh A."/>
<person name="Mizoguchi H."/>
<person name="Goto Y."/>
<person name="Shimizu F."/>
<person name="Wakebe H."/>
<person name="Hishigaki H."/>
<person name="Watanabe T."/>
<person name="Sugiyama A."/>
<person name="Takemoto M."/>
<person name="Kawakami B."/>
<person name="Yamazaki M."/>
<person name="Watanabe K."/>
<person name="Kumagai A."/>
<person name="Itakura S."/>
<person name="Fukuzumi Y."/>
<person name="Fujimori Y."/>
<person name="Komiyama M."/>
<person name="Tashiro H."/>
<person name="Tanigami A."/>
<person name="Fujiwara T."/>
<person name="Ono T."/>
<person name="Yamada K."/>
<person name="Fujii Y."/>
<person name="Ozaki K."/>
<person name="Hirao M."/>
<person name="Ohmori Y."/>
<person name="Kawabata A."/>
<person name="Hikiji T."/>
<person name="Kobatake N."/>
<person name="Inagaki H."/>
<person name="Ikema Y."/>
<person name="Okamoto S."/>
<person name="Okitani R."/>
<person name="Kawakami T."/>
<person name="Noguchi S."/>
<person name="Itoh T."/>
<person name="Shigeta K."/>
<person name="Senba T."/>
<person name="Matsumura K."/>
<person name="Nakajima Y."/>
<person name="Mizuno T."/>
<person name="Morinaga M."/>
<person name="Sasaki M."/>
<person name="Togashi T."/>
<person name="Oyama M."/>
<person name="Hata H."/>
<person name="Watanabe M."/>
<person name="Komatsu T."/>
<person name="Mizushima-Sugano J."/>
<person name="Satoh T."/>
<person name="Shirai Y."/>
<person name="Takahashi Y."/>
<person name="Nakagawa K."/>
<person name="Okumura K."/>
<person name="Nagase T."/>
<person name="Nomura N."/>
<person name="Kikuchi H."/>
<person name="Masuho Y."/>
<person name="Yamashita R."/>
<person name="Nakai K."/>
<person name="Yada T."/>
<person name="Nakamura Y."/>
<person name="Ohara O."/>
<person name="Isogai T."/>
<person name="Sugano S."/>
</authorList>
<dbReference type="PubMed" id="14702039"/>
<dbReference type="DOI" id="10.1038/ng1285"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2)</scope>
<source>
<tissue>Brain</tissue>
<tissue>Lung</tissue>
</source>
</reference>
<reference key="8">
<citation type="submission" date="2005-07" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mural R.J."/>
<person name="Istrail S."/>
<person name="Sutton G.G."/>
<person name="Florea L."/>
<person name="Halpern A.L."/>
<person name="Mobarry C.M."/>
<person name="Lippert R."/>
<person name="Walenz B."/>
<person name="Shatkay H."/>
<person name="Dew I."/>
<person name="Miller J.R."/>
<person name="Flanigan M.J."/>
<person name="Edwards N.J."/>
<person name="Bolanos R."/>
<person name="Fasulo D."/>
<person name="Halldorsson B.V."/>
<person name="Hannenhalli S."/>
<person name="Turner R."/>
<person name="Yooseph S."/>
<person name="Lu F."/>
<person name="Nusskern D.R."/>
<person name="Shue B.C."/>
<person name="Zheng X.H."/>
<person name="Zhong F."/>
<person name="Delcher A.L."/>
<person name="Huson D.H."/>
<person name="Kravitz S.A."/>
<person name="Mouchard L."/>
<person name="Reinert K."/>
<person name="Remington K.A."/>
<person name="Clark A.G."/>
<person name="Waterman M.S."/>
<person name="Eichler E.E."/>
<person name="Adams M.D."/>
<person name="Hunkapiller M.W."/>
<person name="Myers E.W."/>
<person name="Venter J.C."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2)</scope>
<source>
<tissue>Lung</tissue>
</source>
</reference>
<reference key="10">
<citation type="submission" date="1999-02" db="EMBL/GenBank/DDBJ databases">
<authorList>
<person name="Mei G."/>
<person name="Yu W."/>
<person name="Gibbs R.A."/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 22-389 (ISOFORM 4)</scope>
<source>
<tissue>Brain</tissue>
</source>
</reference>
<reference key="11">
<citation type="journal article" date="2001" name="EMBO J." volume="20" first="197" last="209">
<title>A cytosolic NAD-dependent deacetylase, Hst2p, can modulate nucleolar and telomeric silencing in yeast.</title>
<authorList>
<person name="Perrod S."/>
<person name="Cockell M.M."/>
<person name="Laroche T."/>
<person name="Renauld H."/>
<person name="Ducrest A.L."/>
<person name="Bonnard C."/>
<person name="Gasser S.M."/>
</authorList>
<dbReference type="PubMed" id="11226170"/>
<dbReference type="DOI" id="10.1093/emboj/20.1.197"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="38837" last="38843">
<title>Identification of a class of small molecule inhibitors of the sirtuin family of NAD-dependent deacetylases by phenotypic screening.</title>
<authorList>
<person name="Grozinger C.M."/>
<person name="Chao E.D."/>
<person name="Blackwell H.E."/>
<person name="Moazed D."/>
<person name="Schreiber S.L."/>
</authorList>
<dbReference type="PubMed" id="11483616"/>
<dbReference type="DOI" id="10.1074/jbc.m106779200"/>
</citation>
<scope>INHIBITION BY SIRTINOL; A3 AND M15</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>ACTIVITY REGULATION</scope>
</reference>
<reference key="13">
<citation type="journal article" date="2002" name="J. Biol. Chem." volume="277" first="12632" last="12641">
<title>Conserved enzymatic production and biological effect of O-acetyl-ADP-ribose by silent information regulator 2-like NAD+-dependent deacetylases.</title>
<authorList>
<person name="Borra M.T."/>
<person name="O'Neill F.J."/>
<person name="Jackson M.D."/>
<person name="Marshall B.L."/>
<person name="Verdin E."/>
<person name="Foltz K.R."/>
<person name="Denu J.M."/>
</authorList>
<dbReference type="PubMed" id="11812793"/>
<dbReference type="DOI" id="10.1074/jbc.m111830200"/>
</citation>
<scope>CATALYTIC ACTIVITY</scope>
<scope>MUTAGENESIS OF HIS-187</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2003" name="Mol. Cell" volume="11" first="437" last="444">
<title>The human Sir2 ortholog, SIRT2, is an NAD+-dependent tubulin deacetylase.</title>
<authorList>
<person name="North B.J."/>
<person name="Marshall B.L."/>
<person name="Borra M.T."/>
<person name="Denu J.M."/>
<person name="Verdin E."/>
</authorList>
<dbReference type="PubMed" id="12620231"/>
<dbReference type="DOI" id="10.1016/s1097-2765(03)00038-8"/>
</citation>
<scope>FUNCTION IN DEACETYLATION OF TUBULIN</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>INTERACTION WITH HDAC6</scope>
<scope>MUTAGENESIS OF ASN-168 AND HIS-187</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2003" name="Mol. Cell. Biol." volume="23" first="3173" last="3185">
<title>Role for human SIRT2 NAD-dependent deacetylase activity in control of mitotic exit in the cell cycle.</title>
<authorList>
<person name="Dryden S.C."/>
<person name="Nahhas F.A."/>
<person name="Nowak J.E."/>
<person name="Goustin A.-S."/>
<person name="Tainsky M.A."/>
</authorList>
<dbReference type="PubMed" id="12697818"/>
<dbReference type="DOI" id="10.1128/mcb.23.9.3173-3185.2003"/>
</citation>
<scope>FUNCTION AS REGULATOR OF CELL CYCLE PROGRESSION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>DEVELOPMENTAL STAGE</scope>
<scope>PHOSPHORYLATION</scope>
<scope>UBIQUITINATION</scope>
<scope>MUTAGENESIS OF HIS-187</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2003" name="Biochem. Biophys. Res. Commun." volume="309" first="558" last="566">
<title>Proteomics-based identification of differentially expressed genes in human gliomas: down-regulation of SIRT2 gene.</title>
<authorList>
<person name="Hiratsuka M."/>
<person name="Inoue T."/>
<person name="Toda T."/>
<person name="Kimura N."/>
<person name="Shirayoshi Y."/>
<person name="Kamitani H."/>
<person name="Watanabe T."/>
<person name="Ohama E."/>
<person name="Tahimic C.G.T."/>
<person name="Kurimasa A."/>
<person name="Oshimura M."/>
</authorList>
<dbReference type="PubMed" id="12963026"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2003.08.029"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2004" name="J. Biochem." volume="135" first="695" last="700">
<title>Human histone deacetylase SIRT2 interacts with the homeobox transcription factor HOXA10.</title>
<authorList>
<person name="Bae N.S."/>
<person name="Swanson M.J."/>
<person name="Vassilev A."/>
<person name="Howard B.H."/>
</authorList>
<dbReference type="PubMed" id="15213244"/>
<dbReference type="DOI" id="10.1093/jb/mvh084"/>
</citation>
<scope>INTERACTION WITH HOXA10</scope>
</reference>
<reference key="18">
<citation type="journal article" date="2005" name="Mol. Biol. Cell" volume="16" first="4623" last="4635">
<title>Evolutionarily conserved and nonconserved cellular localizations and functions of human SIRT proteins.</title>
<authorList>
<person name="Michishita E."/>
<person name="Park J.Y."/>
<person name="Burneskis J.M."/>
<person name="Barrett J.C."/>
<person name="Horikawa I."/>
</authorList>
<dbReference type="PubMed" id="16079181"/>
<dbReference type="DOI" id="10.1091/mbc.e05-01-0033"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="19">
<citation type="journal article" date="2006" name="Cell" volume="127" first="635" last="648">
<title>Global, in vivo, and site-specific phosphorylation dynamics in signaling networks.</title>
<authorList>
<person name="Olsen J.V."/>
<person name="Blagoev B."/>
<person name="Gnad F."/>
<person name="Macek B."/>
<person name="Kumar C."/>
<person name="Mortensen P."/>
<person name="Mann M."/>
</authorList>
<dbReference type="PubMed" id="17081983"/>
<dbReference type="DOI" id="10.1016/j.cell.2006.09.026"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="20">
<citation type="journal article" date="2006" name="Genes Dev." volume="20" first="1256" last="1261">
<title>SirT2 is a histone deacetylase with preference for histone H4 Lys 16 during mitosis.</title>
<authorList>
<person name="Vaquero A."/>
<person name="Scher M.B."/>
<person name="Lee D.H."/>
<person name="Sutton A."/>
<person name="Cheng H.L."/>
<person name="Alt F.W."/>
<person name="Serrano L."/>
<person name="Sternglanz R."/>
<person name="Reinberg D."/>
</authorList>
<dbReference type="PubMed" id="16648462"/>
<dbReference type="DOI" id="10.1101/gad.1412706"/>
</citation>
<scope>FUNCTION IN DEACETYLATION OF HISTONE H4 AND H3</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>SUBUNIT</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="21">
<citation type="journal article" date="2007" name="J. Biol. Chem." volume="282" first="19546" last="19555">
<title>Mitotic regulation of SIRT2 by cyclin-dependent kinase 1-dependent phosphorylation.</title>
<authorList>
<person name="North B.J."/>
<person name="Verdin E."/>
</authorList>
<dbReference type="PubMed" id="17488717"/>
<dbReference type="DOI" id="10.1074/jbc.m702990200"/>
</citation>
<scope>FUNCTION AS REGULATOR IN CELL CYCLE PROGRESSION</scope>
<scope>PHOSPHORYLATION AT SER-368 BY CDK1</scope>
<scope>DEPHOSPHORYLATION AT SER-368 BY CDC14A AND CDC14B</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF HIS-187 AND SER-368</scope>
</reference>
<reference key="22">
<citation type="journal article" date="2007" name="Mol. Cell. Biochem." volume="303" first="221" last="230">
<title>Mutations in SIRT2 deacetylase which regulate enzymatic activity but not its interaction with HDAC6 and tubulin.</title>
<authorList>
<person name="Nahhas F."/>
<person name="Dryden S.C."/>
<person name="Abrams J."/>
<person name="Tainsky M.A."/>
</authorList>
<dbReference type="PubMed" id="17516032"/>
<dbReference type="DOI" id="10.1007/s11010-007-9478-6"/>
</citation>
<scope>INTERACTION WITH HDAC6 (ISOFORMS 1 AND 2)</scope>
<scope>PHOSPHORYLATION AT SER-372 AND SER-368</scope>
<scope>UBIQUITINATION</scope>
<scope>MUTAGENESIS OF SER-53; SER-98; SER-100; HIS-187; SER-279; THR-280; SER-311; TYR-315; SER-364; SER-368 AND SER-372</scope>
</reference>
<reference key="23">
<citation type="journal article" date="2007" name="Neuroscience" volume="147" first="599" last="612">
<title>Mammalian Sir2-related protein (SIRT) 2-mediated modulation of resistance to axonal degeneration in slow Wallerian degeneration mice: a crucial role of tubulin deacetylation.</title>
<authorList>
<person name="Suzuki K."/>
<person name="Koike T."/>
</authorList>
<dbReference type="PubMed" id="17574768"/>
<dbReference type="DOI" id="10.1016/j.neuroscience.2007.04.059"/>
</citation>
<scope>FUNCTION IN AXONAL DEGENERATION</scope>
</reference>
<reference key="24">
<citation type="journal article" date="2007" name="Oncogene" volume="26" first="945" last="957">
<title>SIRT2, a tubulin deacetylase, acts to block the entry to chromosome condensation in response to mitotic stress.</title>
<authorList>
<person name="Inoue T."/>
<person name="Hiratsuka M."/>
<person name="Osaki M."/>
<person name="Yamada H."/>
<person name="Kishimoto I."/>
<person name="Yamaguchi S."/>
<person name="Nakano S."/>
<person name="Katoh M."/>
<person name="Ito H."/>
<person name="Oshimura M."/>
</authorList>
<dbReference type="PubMed" id="16909107"/>
<dbReference type="DOI" id="10.1038/sj.onc.1209857"/>
</citation>
<scope>FUNCTION AS REGULATOR OF MITOTIC CELL CYCLE CHECKPOINT</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>NUCLEOCYTOPLASMIC SHUTTLING</scope>
<scope>INDUCTION</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>MUTAGENESIS OF GLN-167; ASN-168 AND HIS-187</scope>
</reference>
<reference key="25">
<citation type="journal article" date="2007" name="PLoS ONE" volume="2" first="E784" last="E784">
<title>Interphase nucleo-cytoplasmic shuttling and localization of SIRT2 during mitosis.</title>
<authorList>
<person name="North B.J."/>
<person name="Verdin E."/>
</authorList>
<dbReference type="PubMed" id="17726514"/>
<dbReference type="DOI" id="10.1371/journal.pone.0000784"/>
</citation>
<scope>FUNCTION AS REGULATOR IN CELL CYCLE PROGRESSION</scope>
<scope>INTERACTION WITH AURKA</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>NUCLEOCYTOPLASMIC SHUTTLING</scope>
<scope>MUTAGENESIS OF HIS-187</scope>
</reference>
<reference key="26">
<citation type="journal article" date="2008" name="Biochem. Biophys. Res. Commun." volume="368" first="690" last="695">
<title>Sirt2 interacts with 14-3-3 beta/gamma and down-regulates the activity of p53.</title>
<authorList>
<person name="Jin Y.H."/>
<person name="Kim Y.J."/>
<person name="Kim D.W."/>
<person name="Baek K.H."/>
<person name="Kang B.Y."/>
<person name="Yeo C.Y."/>
<person name="Lee K.Y."/>
</authorList>
<dbReference type="PubMed" id="18249187"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2008.01.114"/>
</citation>
<scope>FUNCTION IN DEACETYLATION OF TP53</scope>
<scope>FUNCTION IN REGULATION OF TP53</scope>
<scope>INTERACTION WITH YWHAB AND YWHAG</scope>
</reference>
<reference key="27">
<citation type="journal article" date="2008" name="Biochem. Biophys. Res. Commun." volume="375" first="576" last="580">
<title>Acetylation of Sirt2 by p300 attenuates its deacetylase activity.</title>
<authorList>
<person name="Han Y."/>
<person name="Jin Y.H."/>
<person name="Kim Y.J."/>
<person name="Kang B.Y."/>
<person name="Choi H.J."/>
<person name="Kim D.W."/>
<person name="Yeo C.Y."/>
<person name="Lee K.Y."/>
</authorList>
<dbReference type="PubMed" id="18722353"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2008.08.042"/>
</citation>
<scope>INTERACTION WITH EP300</scope>
<scope>ACETYLATION BY EP300</scope>
<scope>ACTIVITY REGULATION</scope>
<scope>CATALYTIC ACTIVITY</scope>
</reference>
<reference key="28">
<citation type="journal article" date="2008" name="FEBS Lett." volume="582" first="2857" last="2862">
<title>SIRT2 is a negative regulator of anoxia-reoxygenation tolerance via regulation of 14-3-3 zeta and BAD in H9c2 cells.</title>
<authorList>
<person name="Lynn E.G."/>
<person name="McLeod C.J."/>
<person name="Gordon J.P."/>
<person name="Bao J."/>
<person name="Sack M.N."/>
</authorList>
<dbReference type="PubMed" id="18640115"/>
<dbReference type="DOI" id="10.1016/j.febslet.2008.07.016"/>
</citation>
<scope>FUNCTION IN STRESS RESPONSE</scope>
<scope>INDUCTION BY STRESS</scope>
</reference>
<reference key="29">
<citation type="journal article" date="2008" name="J. Cell Biol." volume="180" first="915" last="929">
<title>The regulation of SIRT2 function by cyclin-dependent kinases affects cell motility.</title>
<authorList>
<person name="Pandithage R."/>
<person name="Lilischkis R."/>
<person name="Harting K."/>
<person name="Wolf A."/>
<person name="Jedamzik B."/>
<person name="Luscher-Firzlaff J."/>
<person name="Vervoorts J."/>
<person name="Lasonder E."/>
<person name="Kremmer E."/>
<person name="Knoll B."/>
<person name="Luscher B."/>
</authorList>
<dbReference type="PubMed" id="18332217"/>
<dbReference type="DOI" id="10.1083/jcb.200707126"/>
</citation>
<scope>FUNCTION IN DEACETYLATION OF ALPHA-TUBULIN AND HISTONE</scope>
<scope>FUNCTION IN REGULATION OF CELL MOTILITY</scope>
<scope>INTERACTION WITH CDK5R1; CDK5 AND CYCLIN E-CDK2 COMPLEX</scope>
<scope>PHOSPHORYLATION AT SER-368 BY CDK2 AND CDK5</scope>
<scope>MUTAGENESIS OF SER-368</scope>
</reference>
<reference key="30">
<citation type="journal article" date="2008" name="Mol. Cell" volume="32" first="449" last="455">
<title>The SIRT2 deacetylase regulates autoacetylation of p300.</title>
<authorList>
<person name="Black J.C."/>
<person name="Mosley A."/>
<person name="Kitada T."/>
<person name="Washburn M."/>
<person name="Carey M."/>
</authorList>
<dbReference type="PubMed" id="18995842"/>
<dbReference type="DOI" id="10.1016/j.molcel.2008.09.018"/>
</citation>
<scope>FUNCTION IN DEACETYLATION OF EP300 AND ALPHA-TUBULIN</scope>
<scope>FUNCTION IN REGULATION OF EP300</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="31">
<citation type="journal article" date="2008" name="Proc. Natl. Acad. Sci. U.S.A." volume="105" first="10762" last="10767">
<title>A quantitative atlas of mitotic phosphorylation.</title>
<authorList>
<person name="Dephoure N."/>
<person name="Zhou C."/>
<person name="Villen J."/>
<person name="Beausoleil S.A."/>
<person name="Bakalarski C.E."/>
<person name="Elledge S.J."/>
<person name="Gygi S.P."/>
</authorList>
<dbReference type="PubMed" id="18669648"/>
<dbReference type="DOI" id="10.1073/pnas.0805139105"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
</source>
</reference>
<reference key="32">
<citation type="journal article" date="2009" name="Anal. Chem." volume="81" first="4493" last="4501">
<title>Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach.</title>
<authorList>
<person name="Gauci S."/>
<person name="Helbig A.O."/>
<person name="Slijper M."/>
<person name="Krijgsveld J."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="19413330"/>
<dbReference type="DOI" id="10.1021/ac9004309"/>
</citation>
<scope>ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2</scope>
<scope>CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE ANALYSIS]</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
</reference>
<reference key="33">
<citation type="journal article" date="2009" name="Cell Cycle" volume="8" first="1279" last="1291">
<title>SIRT2 downregulation confers resistance to microtubule inhibitors by prolonging chronic mitotic arrest.</title>
<authorList>
<person name="Inoue T."/>
<person name="Nakayama Y."/>
<person name="Yamada H."/>
<person name="Li Y.C."/>
<person name="Yamaguchi S."/>
<person name="Osaki M."/>
<person name="Kurimasa A."/>
<person name="Hiratsuka M."/>
<person name="Katoh M."/>
<person name="Oshimura M."/>
</authorList>
<dbReference type="PubMed" id="19282667"/>
<dbReference type="DOI" id="10.4161/cc.8.8.8245"/>
</citation>
<scope>FUNCTION AS REGULATOR OF MITOTIC CELL CYCLE CHECKPOINT</scope>
</reference>
<reference key="34">
<citation type="journal article" date="2009" name="Sci. Signal." volume="2" first="RA46" last="RA46">
<title>Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions.</title>
<authorList>
<person name="Mayya V."/>
<person name="Lundgren D.H."/>
<person name="Hwang S.-I."/>
<person name="Rezaul K."/>
<person name="Wu L."/>
<person name="Eng J.K."/>
<person name="Rodionov V."/>
<person name="Han D.K."/>
</authorList>
<dbReference type="PubMed" id="19690332"/>
<dbReference type="DOI" id="10.1126/scisignal.2000007"/>
</citation>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Leukemic T-cell</tissue>
</source>
</reference>
<reference key="35">
<citation type="journal article" date="2010" name="J. Biol. Chem." volume="285" first="28553" last="28564">
<title>p300-mediated acetylation of histone H3 lysine 56 functions in DNA damage response in mammals.</title>
<authorList>
<person name="Vempati R.K."/>
<person name="Jayani R.S."/>
<person name="Notani D."/>
<person name="Sengupta A."/>
<person name="Galande S."/>
<person name="Haldar D."/>
</authorList>
<dbReference type="PubMed" id="20587414"/>
<dbReference type="DOI" id="10.1074/jbc.m110.149393"/>
</citation>
<scope>FUNCTION IN DEACETYLATION OF HISTONE H3</scope>
</reference>
<reference key="36">
<citation type="journal article" date="2010" name="J. Cell Sci." volume="123" first="4251" last="4258">
<title>SIRT2 regulates NF-kappaB dependent gene expression through deacetylation of p65 Lys310.</title>
<authorList>
<person name="Rothgiesser K.M."/>
<person name="Erener S."/>
<person name="Waibel S."/>
<person name="Luscher B."/>
<person name="Hottiger M.O."/>
</authorList>
<dbReference type="PubMed" id="21081649"/>
<dbReference type="DOI" id="10.1242/jcs.073783"/>
</citation>
<scope>FUNCTION IN DEACETYLATION OF RELA</scope>
<scope>FUNCTION IN REGULATION OF RELA ACTIVITY</scope>
<scope>INTERACTION WITH RELA</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="37">
<citation type="journal article" date="2010" name="Nat. Cell Biol." volume="12" first="665" last="675">
<title>Cytosolic FoxO1 is essential for the induction of autophagy and tumour suppressor activity.</title>
<authorList>
<person name="Zhao Y."/>
<person name="Yang J."/>
<person name="Liao W."/>
<person name="Liu X."/>
<person name="Zhang H."/>
<person name="Wang S."/>
<person name="Wang D."/>
<person name="Feng J."/>
<person name="Yu L."/>
<person name="Zhu W.G."/>
</authorList>
<dbReference type="PubMed" id="20543840"/>
<dbReference type="DOI" id="10.1038/ncb2069"/>
</citation>
<scope>FUNCTION IN DEACETYLATION OF FOXO1</scope>
<scope>FUNCTION IN AUTOPHAGY</scope>
<scope>INTERACTION WITH FOXO1</scope>
</reference>
<reference key="38">
<citation type="journal article" date="2011" name="Cancer Cell" volume="20" first="487" last="499">
<title>SIRT2 maintains genome integrity and suppresses tumorigenesis through regulating APC/C activity.</title>
<authorList>
<person name="Kim H.S."/>
<person name="Vassilopoulos A."/>
<person name="Wang R.H."/>
<person name="Lahusen T."/>
<person name="Xiao Z."/>
<person name="Xu X."/>
<person name="Li C."/>
<person name="Veenstra T.D."/>
<person name="Li B."/>
<person name="Yu H."/>
<person name="Ji J."/>
<person name="Wang X.W."/>
<person name="Park S.H."/>
<person name="Cha Y.I."/>
<person name="Gius D."/>
<person name="Deng C.X."/>
</authorList>
<dbReference type="PubMed" id="22014574"/>
<dbReference type="DOI" id="10.1016/j.ccr.2011.09.004"/>
</citation>
<scope>FUNCTION IN DEACETYLATION OF CDC20 AND FZR1</scope>
<scope>FUNCTION AS A TUMOR SUPPRESSOR</scope>
<scope>TISSUE SPECIFICITY</scope>
<scope>MUTAGENESIS OF HIS-187</scope>
</reference>
<reference key="39">
<citation type="journal article" date="2011" name="Hum. Mol. Genet." volume="20" first="3986" last="3996">
<title>The Sirtuin 2 microtubule deacetylase is an abundant neuronal protein that accumulates in the aging CNS.</title>
<authorList>
<person name="Maxwell M.M."/>
<person name="Tomkinson E.M."/>
<person name="Nobles J."/>
<person name="Wizeman J.W."/>
<person name="Amore A.M."/>
<person name="Quinti L."/>
<person name="Chopra V."/>
<person name="Hersch S.M."/>
<person name="Kazantsev A.G."/>
</authorList>
<dbReference type="PubMed" id="21791548"/>
<dbReference type="DOI" id="10.1093/hmg/ddr326"/>
</citation>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="40">
<citation type="journal article" date="2011" name="Mol. Cell" volume="43" first="33" last="44">
<title>Acetylation regulates gluconeogenesis by promoting PEPCK1 degradation via recruiting the UBR5 ubiquitin ligase.</title>
<authorList>
<person name="Jiang W."/>
<person name="Wang S."/>
<person name="Xiao M."/>
<person name="Lin Y."/>
<person name="Zhou L."/>
<person name="Lei Q."/>
<person name="Xiong Y."/>
<person name="Guan K.L."/>
<person name="Zhao S."/>
</authorList>
<dbReference type="PubMed" id="21726808"/>
<dbReference type="DOI" id="10.1016/j.molcel.2011.04.028"/>
</citation>
<scope>FUNCTION IN DEACETYLATION OF PCK1</scope>
<scope>POSSIBLE FUNCTION IN REGULATION OF BLOOD GLUCOSE HOMEOSTASIS</scope>
<scope>INDUCTION BY GLUCOSE</scope>
</reference>
<reference key="41">
<citation type="journal article" date="2011" name="Proc. Natl. Acad. Sci. U.S.A." volume="108" first="E952" last="961">
<title>Sir-two-homolog 2 (Sirt2) modulates peripheral myelination through polarity protein Par-3/atypical protein kinase C (aPKC) signaling.</title>
<authorList>
<person name="Beirowski B."/>
<person name="Gustin J."/>
<person name="Armour S.M."/>
<person name="Yamamoto H."/>
<person name="Viader A."/>
<person name="North B.J."/>
<person name="Michan S."/>
<person name="Baloh R.H."/>
<person name="Golden J.P."/>
<person name="Schmidt R.E."/>
<person name="Sinclair D.A."/>
<person name="Auwerx J."/>
<person name="Milbrandt J."/>
</authorList>
<dbReference type="PubMed" id="21949390"/>
<dbReference type="DOI" id="10.1073/pnas.1104969108"/>
</citation>
<scope>FUNCTION IN DEACETYLATION OF PARD3</scope>
<scope>INTERACTION WITH PARD3</scope>
</reference>
<reference key="42">
<citation type="journal article" date="2012" name="FEBS Lett." volume="586" first="3236" last="3241">
<title>Acetylation regulates subcellular localization of eukaryotic translation initiation factor 5A (eIF5A).</title>
<authorList>
<person name="Ishfaq M."/>
<person name="Maeta K."/>
<person name="Maeda S."/>
<person name="Natsume T."/>
<person name="Ito A."/>
<person name="Yoshida M."/>
</authorList>
<dbReference type="PubMed" id="22771473"/>
<dbReference type="DOI" id="10.1016/j.febslet.2012.06.042"/>
</citation>
<scope>FUNCTION IN DEACETYLATION OF EIF5A</scope>
</reference>
<reference key="43">
<citation type="journal article" date="2012" name="Neurochem. Int." volume="61" first="992" last="1000">
<title>SIRT2 interferes with autophagy-mediated degradation of protein aggregates in neuronal cells under proteasome inhibition.</title>
<authorList>
<person name="Gal J."/>
<person name="Bang Y."/>
<person name="Choi H.J."/>
</authorList>
<dbReference type="PubMed" id="22819792"/>
<dbReference type="DOI" id="10.1016/j.neuint.2012.07.010"/>
</citation>
<scope>FUNCTION IN AUTOPHAGY</scope>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="44">
<citation type="journal article" date="2012" name="Transl. Cancer Res." volume="1" first="15" last="21">
<title>SIRT2 is a tumor suppressor that connects aging, acetylome, cell cycle signaling, and carcinogenesis.</title>
<authorList>
<person name="Park S.H."/>
<person name="Zhu Y."/>
<person name="Ozden O."/>
<person name="Kim H.S."/>
<person name="Jiang H."/>
<person name="Deng C.X."/>
<person name="Gius D."/>
<person name="Vassilopoulos A."/>
</authorList>
<dbReference type="PubMed" id="22943040"/>
</citation>
<scope>REVIEW</scope>
<scope>FUNCTION AS A TUMOR SUPPRESSOR</scope>
</reference>
<reference key="45">
<citation type="journal article" date="2013" name="Biochem. Biophys. Res. Commun." volume="437" first="245" last="249">
<title>ERK1/2 regulates SIRT2 deacetylase activity.</title>
<authorList>
<person name="Choi Y.H."/>
<person name="Kim H."/>
<person name="Lee S.H."/>
<person name="Jin Y.H."/>
<person name="Lee K.Y."/>
</authorList>
<dbReference type="PubMed" id="23806683"/>
<dbReference type="DOI" id="10.1016/j.bbrc.2013.06.053"/>
</citation>
<scope>INTERACTION WITH MAPK1/ERK2 AND MAPK3/ERK1</scope>
</reference>
<reference key="46">
<citation type="journal article" date="2013" name="Genes Dev." volume="27" first="639" last="653">
<title>The tumor suppressor SirT2 regulates cell cycle progression and genome stability by modulating the mitotic deposition of H4K20 methylation.</title>
<authorList>
<person name="Serrano L."/>
<person name="Martinez-Redondo P."/>
<person name="Marazuela-Duque A."/>
<person name="Vazquez B.N."/>
<person name="Dooley S.J."/>
<person name="Voigt P."/>
<person name="Beck D.B."/>
<person name="Kane-Goldsmith N."/>
<person name="Tong Q."/>
<person name="Rabanal R.M."/>
<person name="Fondevila D."/>
<person name="Munoz P."/>
<person name="Kruger M."/>
<person name="Tischfield J.A."/>
<person name="Vaquero A."/>
</authorList>
<dbReference type="PubMed" id="23468428"/>
<dbReference type="DOI" id="10.1101/gad.211342.112"/>
</citation>
<scope>FUNCTION IN DEACETYLATION OF HISTONE H4K16 AND KMT5A</scope>
<scope>FUNCTION IN REGULATION OF KMT5A ACTIVITY; H4K20 METHYLATION; CELL CYCLE PROGRESSION AND GENOMIC STABILITY</scope>
<scope>INTERACTION WITH KMT5A</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MASS SPECTROMETRY</scope>
</reference>
<reference key="47">
<citation type="journal article" date="2013" name="J. Proteome Res." volume="12" first="260" last="271">
<title>Toward a comprehensive characterization of a human cancer cell phosphoproteome.</title>
<authorList>
<person name="Zhou H."/>
<person name="Di Palma S."/>
<person name="Preisinger C."/>
<person name="Peng M."/>
<person name="Polat A.N."/>
<person name="Heck A.J."/>
<person name="Mohammed S."/>
</authorList>
<dbReference type="PubMed" id="23186163"/>
<dbReference type="DOI" id="10.1021/pr300630k"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-368</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Cervix carcinoma</tissue>
<tissue>Erythroleukemia</tissue>
</source>
</reference>
<reference key="48">
<citation type="journal article" date="2013" name="Mol. Cell" volume="51" first="506" last="518">
<title>Acetylation stabilizes ATP-citrate lyase to promote lipid biosynthesis and tumor growth.</title>
<authorList>
<person name="Lin R."/>
<person name="Tao R."/>
<person name="Gao X."/>
<person name="Li T."/>
<person name="Zhou X."/>
<person name="Guan K.L."/>
<person name="Xiong Y."/>
<person name="Lei Q.Y."/>
</authorList>
<dbReference type="PubMed" id="23932781"/>
<dbReference type="DOI" id="10.1016/j.molcel.2013.07.002"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="49">
<citation type="journal article" date="2013" name="Science" volume="341" first="1238858" last="1238858">
<title>A role for SIRT2-dependent histone H3K18 deacetylation in bacterial infection.</title>
<authorList>
<person name="Eskandarian H.A."/>
<person name="Impens F."/>
<person name="Nahori M.A."/>
<person name="Soubigou G."/>
<person name="Coppee J.Y."/>
<person name="Cossart P."/>
<person name="Hamon M.A."/>
</authorList>
<dbReference type="PubMed" id="23908241"/>
<dbReference type="DOI" id="10.1126/science.1238858"/>
</citation>
<scope>FUNCTION IN DEACETYLATION OF HISTONE H3K18</scope>
<scope>FUNCTION IN LISTERIA INFECTION</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MUTAGENESIS OF ASN-168</scope>
</reference>
<reference key="50">
<citation type="journal article" date="2014" name="Elife" volume="3" first="E02349" last="E02349">
<title>tRNA synthetase counteracts c-Myc to develop functional vasculature.</title>
<authorList>
<person name="Shi Y."/>
<person name="Xu X."/>
<person name="Zhang Q."/>
<person name="Fu G."/>
<person name="Mo Z."/>
<person name="Wang G.S."/>
<person name="Kishi S."/>
<person name="Yang X.L."/>
</authorList>
<dbReference type="PubMed" id="24940000"/>
<dbReference type="DOI" id="10.7554/elife.02349"/>
</citation>
<scope>FUNCTION IN HISTONE H4 DEACETYLATION</scope>
<scope>FUNCTION IN REGULATION OF VEGFA EXPRESSION AND ANGIOGENESIS</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>INTERACTION WITH SARS1</scope>
</reference>
<reference key="51">
<citation type="journal article" date="2014" name="EMBO J." volume="33" first="1304" last="1320">
<title>Regulation of G6PD acetylation by KAT9/SIRT2 modulates NADPH homeostasis and cell survival during oxidative stress.</title>
<authorList>
<person name="Wang Y.P."/>
<person name="Zhou L.S."/>
<person name="Zhao Y.Z."/>
<person name="Wang S.W."/>
<person name="Chen L.L."/>
<person name="Liu L.X."/>
<person name="Ling Z.Q."/>
<person name="Hu F.J."/>
<person name="Sun Y.P."/>
<person name="Zhang J.Y."/>
<person name="Yang C."/>
<person name="Yang Y."/>
<person name="Xiong Y."/>
<person name="Guan K.L."/>
<person name="Ye D."/>
</authorList>
<dbReference type="PubMed" id="24769394"/>
<dbReference type="DOI" id="10.1002/embj.201387224"/>
</citation>
<scope>FUNCTION IN DEACETYLATION OF G6PD</scope>
<scope>FUNCTION IN REGULATION OF G6PD ACTIVITY</scope>
<scope>INTERACTION WITH G6PD</scope>
<scope>MUTAGENESIS OF ASN-168</scope>
</reference>
<reference key="52">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-23; SER-25 AND SER-27</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="53">
<citation type="journal article" date="2015" name="Oncogene" volume="34" first="1354" last="1362">
<title>SIRT2 regulates tumour hypoxia response by promoting HIF-1alpha hydroxylation.</title>
<authorList>
<person name="Seo K.S."/>
<person name="Park J.H."/>
<person name="Heo J.Y."/>
<person name="Jing K."/>
<person name="Han J."/>
<person name="Min K.N."/>
<person name="Kim C."/>
<person name="Koh G.Y."/>
<person name="Lim K."/>
<person name="Kang G.Y."/>
<person name="Uee Lee J."/>
<person name="Yim Y.H."/>
<person name="Shong M."/>
<person name="Kwak T.H."/>
<person name="Kweon G.R."/>
</authorList>
<dbReference type="PubMed" id="24681946"/>
<dbReference type="DOI" id="10.1038/onc.2014.76"/>
</citation>
<scope>FUNCTION IN DEACETYLATION OF HIF1A</scope>
<scope>FUNCTION IN REGULATION OF HIF1A STABILITY</scope>
<scope>INTERACTION WITH HIF1A</scope>
<scope>MUTAGENESIS OF HIS-187</scope>
<scope>SUBCELLULAR LOCATION</scope>
<scope>MASS SPECTROMETRY</scope>
</reference>
<reference key="54">
<citation type="journal article" date="2016" name="Cell Death Dis." volume="7" first="E2336" last="E2336">
<title>Oncogenic microtubule hyperacetylation through BEX4-mediated sirtuin 2 inhibition.</title>
<authorList>
<person name="Lee J.K."/>
<person name="Lee J."/>
<person name="Go H."/>
<person name="Lee C.G."/>
<person name="Kim S."/>
<person name="Kim H.S."/>
<person name="Cho H."/>
<person name="Choi K.S."/>
<person name="Ha G.H."/>
<person name="Lee C.W."/>
</authorList>
<dbReference type="PubMed" id="27512957"/>
<dbReference type="DOI" id="10.1038/cddis.2016.240"/>
</citation>
<scope>INTERACTION WITH BEX4</scope>
<scope>MUTAGENESIS OF HIS-187</scope>
</reference>
<reference key="55">
<citation type="journal article" date="2001" name="Nat. Struct. Biol." volume="8" first="621" last="625">
<title>Structure of the histone deacetylase SIRT2.</title>
<authorList>
<person name="Finnin M.S."/>
<person name="Donigian J.R."/>
<person name="Pavletich N.P."/>
</authorList>
<dbReference type="PubMed" id="11427894"/>
<dbReference type="DOI" id="10.1038/89668"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 34-356 IN COMPLEX WITH ZINC</scope>
<scope>MUTAGENESIS OF ARG-97; GLN-167; ASN-168; ASP-170 AND HIS-187</scope>
</reference>
<reference key="56">
<citation type="journal article" date="2013" name="J. Struct. Biol." volume="182" first="136" last="143">
<title>Crystal structure analysis of human Sirt2 and its ADP-ribose complex.</title>
<authorList>
<person name="Moniot S."/>
<person name="Schutkowski M."/>
<person name="Steegborn C."/>
</authorList>
<dbReference type="PubMed" id="23454361"/>
<dbReference type="DOI" id="10.1016/j.jsb.2013.02.012"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.63 ANGSTROMS) OF 34-356 IN COMPLEX WITH NAD ANALOG AND ZINC</scope>
</reference>
<reference key="57">
<citation type="journal article" date="2014" name="Structure" volume="22" first="345" last="352">
<title>Structural basis for potent inhibition of SIRT2 deacetylase by a macrocyclic peptide inducing dynamic structural change.</title>
<authorList>
<person name="Yamagata K."/>
<person name="Goto Y."/>
<person name="Nishimasu H."/>
<person name="Morimoto J."/>
<person name="Ishitani R."/>
<person name="Dohmae N."/>
<person name="Takeda N."/>
<person name="Nagai R."/>
<person name="Komuro I."/>
<person name="Suga H."/>
<person name="Nureki O."/>
</authorList>
<dbReference type="PubMed" id="24389023"/>
<dbReference type="DOI" id="10.1016/j.str.2013.12.001"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (2.52 ANGSTROMS) OF 55-356 IN COMPLEX WITH PEPTIDE INHIBITOR AND ZINC</scope>
<scope>ACTIVITY REGULATION</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>MUTAGENESIS OF GLU-116; GLU-120; PHE-244; GLN-265; SER-271 AND ASP-294</scope>
</reference>
<reference key="58" evidence="3 4 5 6">
<citation type="journal article" date="2015" name="Nat. Commun." volume="6" first="6263" last="6263">
<title>Selective Sirt2 inhibition by ligand-induced rearrangement of the active site.</title>
<authorList>
<person name="Rumpf T."/>
<person name="Schiedel M."/>
<person name="Karaman B."/>
<person name="Roessler C."/>
<person name="North B.J."/>
<person name="Lehotzky A."/>
<person name="Olah J."/>
<person name="Ladwein K.I."/>
<person name="Schmidtkunz K."/>
<person name="Gajer M."/>
<person name="Pannek M."/>
<person name="Steegborn C."/>
<person name="Sinclair D.A."/>
<person name="Gerhardt S."/>
<person name="Ovadi J."/>
<person name="Schutkowski M."/>
<person name="Sippl W."/>
<person name="Einsle O."/>
<person name="Jung M."/>
</authorList>
<dbReference type="PubMed" id="25672491"/>
<dbReference type="DOI" id="10.1038/ncomms7263"/>
</citation>
<scope>X-RAY CRYSTALLOGRAPHY (1.42 ANGSTROMS) OF 56-356 IN COMPLEX WITH NAD AND ZINC</scope>
<scope>CATALYTIC ACTIVITY</scope>
<scope>COFACTOR</scope>
</reference>
<comment type="function">
<text evidence="15 22 23 26 27 28 30 31 32 33 34 35 36 37 38 39 40 41 43 44 45 46 48 50 51 52 54 55 56">NAD-dependent protein deacetylase, which deacetylates internal lysines on histone and alpha-tubulin as well as many other proteins such as key transcription factors (PubMed:24177535, PubMed:12620231, PubMed:16648462, PubMed:18249187, PubMed:18332217, PubMed:18995842, PubMed:20587414, PubMed:21081649, PubMed:20543840, PubMed:22014574, PubMed:21726808, PubMed:21949390, PubMed:22771473, PubMed:23468428, PubMed:23908241, PubMed:24940000, PubMed:24769394, PubMed:24681946). Participates in the modulation of multiple and diverse biological processes such as cell cycle control, genomic integrity, microtubule dynamics, cell differentiation, metabolic networks, and autophagy. Plays a major role in the control of cell cycle progression and genomic stability. Functions in the antephase checkpoint preventing precocious mitotic entry in response to microtubule stress agents, and hence allowing proper inheritance of chromosomes. Positively regulates the anaphase promoting complex/cyclosome (APC/C) ubiquitin ligase complex activity by deacetylating CDC20 and FZR1, then allowing progression through mitosis. Associates both with chromatin at transcriptional start sites (TSSs) and enhancers of active genes. Plays a role in cell cycle and chromatin compaction through epigenetic modulation of the regulation of histone H4 'Lys-20' methylation (H4K20me1) during early mitosis. Specifically deacetylates histone H4 at 'Lys-16' (H4K16ac) between the G2/M transition and metaphase enabling H4K20me1 deposition by KMT5A leading to ulterior levels of H4K20me2 and H4K20me3 deposition throughout cell cycle, and mitotic S-phase progression (PubMed:23468428). Deacetylates KMT5A modulating KMT5A chromatin localization during the mitotic stress response (PubMed:23468428). Deacetylates also histone H3 at 'Lys-57' (H3K56ac) during the mitotic G2/M transition. Upon bacterium Listeria monocytogenes infection, deacetylates 'Lys-18' of histone H3 in a receptor tyrosine kinase MET- and PI3K/Akt-dependent manner, thereby inhibiting transcriptional activity and promoting late stages of listeria infection (PubMed:23908241). During oocyte meiosis progression, may deacetylate histone H4 at 'Lys-16' (H4K16ac) and alpha-tubulin, regulating spindle assembly and chromosome alignment by influencing microtubule dynamics and kinetochore function. Deacetylates histone H4 at 'Lys-16' (H4K16ac) at the VEGFA promoter and thereby contributes to regulate expression of VEGFA, a key regulator of angiogenesis (PubMed:24940000). Deacetylates alpha-tubulin at 'Lys-40' and hence controls neuronal motility, oligodendroglial cell arbor projection processes and proliferation of non-neuronal cells. Phosphorylation at Ser-368 by a G1/S-specific cyclin E-CDK2 complex inactivates SIRT2-mediated alpha-tubulin deacetylation, negatively regulating cell adhesion, cell migration and neurite outgrowth during neuronal differentiation. Deacetylates PARD3 and participates in the regulation of Schwann cell peripheral myelination formation during early postnatal development and during postinjury remyelination. Involved in several cellular metabolic pathways. Plays a role in the regulation of blood glucose homeostasis by deacetylating and stabilizing phosphoenolpyruvate carboxykinase PCK1 activity in response to low nutrient availability. Acts as a key regulator in the pentose phosphate pathway (PPP) by deacetylating and activating the glucose-6-phosphate G6PD enzyme, and therefore, stimulates the production of cytosolic NADPH to counteract oxidative damage. Maintains energy homeostasis in response to nutrient deprivation as well as energy expenditure by inhibiting adipogenesis and promoting lipolysis. Attenuates adipocyte differentiation by deacetylating and promoting FOXO1 interaction to PPARG and subsequent repression of PPARG-dependent transcriptional activity. Plays a role in the regulation of lysosome-mediated degradation of protein aggregates by autophagy in neuronal cells. Deacetylates FOXO1 in response to oxidative stress or serum deprivation, thereby negatively regulating FOXO1-mediated autophagy (PubMed:20543840). Deacetylates a broad range of transcription factors and co-regulators regulating target gene expression. Deacetylates transcriptional factor FOXO3 stimulating the ubiquitin ligase SCF(SKP2)-mediated FOXO3 ubiquitination and degradation (By similarity). Deacetylates HIF1A and therefore promotes HIF1A degradation and inhibition of HIF1A transcriptional activity in tumor cells in response to hypoxia (PubMed:24681946). Deacetylates RELA in the cytoplasm inhibiting NF-kappaB-dependent transcription activation upon TNF-alpha stimulation. Inhibits transcriptional activation by deacetylating p53/TP53 and EP300 (PubMed:18249187). Deacetylates also EIF5A (PubMed:22771473). Functions as a negative regulator on oxidative stress-tolerance in response to anoxia-reoxygenation conditions. Plays a role as tumor suppressor (PubMed:22014574).</text>
</comment>
<comment type="function">
<molecule>Isoform 1</molecule>
<text evidence="52">Deacetylates EP300, alpha-tubulin and histone H3 and H4.</text>
</comment>
<comment type="function">
<molecule>Isoform 2</molecule>
<text evidence="52">Deacetylates EP300, alpha-tubulin and histone H3 and H4.</text>
</comment>
<comment type="function">
<molecule>Isoform 5</molecule>
<text evidence="52">Lacks deacetylation activity.</text>
</comment>
<comment type="catalytic activity">
<reaction evidence="16 20 21 26 35 52 53 56 57">
<text>H2O + N(6)-acetyl-L-lysyl-[protein] + NAD(+) = 2''-O-acetyl-ADP-D-ribose + L-lysyl-[protein] + nicotinamide</text>
<dbReference type="Rhea" id="RHEA:43636"/>
<dbReference type="Rhea" id="RHEA-COMP:9752"/>
<dbReference type="Rhea" id="RHEA-COMP:10731"/>
<dbReference type="ChEBI" id="CHEBI:15377"/>
<dbReference type="ChEBI" id="CHEBI:17154"/>
<dbReference type="ChEBI" id="CHEBI:29969"/>
<dbReference type="ChEBI" id="CHEBI:57540"/>
<dbReference type="ChEBI" id="CHEBI:61930"/>
<dbReference type="ChEBI" id="CHEBI:83767"/>
<dbReference type="EC" id="2.3.1.286"/>
</reaction>
</comment>
<comment type="cofactor">
<cofactor evidence="57">
<name>Zn(2+)</name>
<dbReference type="ChEBI" id="CHEBI:29105"/>
</cofactor>
<text evidence="57">Binds 1 zinc ion per subunit.</text>
</comment>
<comment type="activity regulation">
<text evidence="20 35 53">Inhibited by Sirtinol, A3 and M15 small molecules (PubMed:11483616). Inhibited by nicotinamide. Inhibited by a macrocyclic peptide inhibitor S2iL5 (PubMed:24389023). Inhibited by EP300-induced acetylation (PubMed:18722353).</text>
</comment>
<comment type="subunit">
<text evidence="13 15 19 22 25 26 31 32 33 35 38 40 43 47 48 49 52 53 54 55 56 58">Interacts with CDC20, FOXO3 and FZR1. Associates with microtubules in primary cortical mature neurons (By similarity). Homotrimer. Isoform 1 and isoform 2 interact (via both phosphorylated, unphosphorylated, active or inactive forms) with HDAC6; the interaction is necessary for the complex to interact with alpha-tubulin, suggesting that these proteins belong to a large complex that deacetylates the cytoskeleton. Interacts with FOXO1; the interaction is disrupted upon serum-starvation or oxidative stress, leading to increased level of acetylated FOXO1 and induction of autophagy. Interacts with RELA; the interaction occurs in the cytoplasm and is increased in a TNF-alpha-dependent manner. Interacts with HOXA10; the interaction is direct. Interacts with YWHAB and YWHAG; the interactions occur in a AKT-dependent manner and increase SIRT2-dependent TP53 deacetylation. Interacts with MAPK1/ERK2 and MAPK3/ERK1; the interactions increase SIRT2 stability and deacetylation activity. Interacts (phosphorylated form) with KMT5A isoform 2; the interaction is direct, stimulates KMT5A-mediated methyltransferase activity on histone at 'Lys-20' (H4K20me1) and is increased in a H(2)O(2)-induced oxidative stress-dependent manner. Interacts with G6PD; the interaction is enhanced by H(2)O(2) treatment. Interacts with a G1/S-specific cyclin E-CDK2 complex. Interacts with AURKA, CDK5R1 (p35 form) and CDK5 and HIF1A. Isoform 1, isoform 2 and isoform 5 interact (via C-terminus region) with EP300 (PubMed:24177535). Interacts with the tRNA ligase SARS1; recruited to the VEGFA promoter via interaction with SARS1 (PubMed:24940000). Interacts with BEX4; negatively regulates alpha-tubulin deacetylation by SIRT2 (PubMed:27512957).</text>
</comment>
<comment type="interaction">
<interactant intactId="EBI-477232">
<id>Q8IXJ6</id>
</interactant>
<interactant intactId="EBI-1001438">
<id>O60566</id>
<label>BUB1B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-477232">
<id>Q8IXJ6</id>
</interactant>
<interactant intactId="EBI-970231">
<id>O60729</id>
<label>CDC14B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-477232">
<id>Q8IXJ6</id>
</interactant>
<interactant intactId="EBI-4289891">
<id>P11413</id>
<label>G6PD</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>3</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-477232">
<id>Q8IXJ6</id>
</interactant>
<interactant intactId="EBI-477430">
<id>Q92831</id>
<label>KAT2B</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>4</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-477232">
<id>Q8IXJ6</id>
</interactant>
<interactant intactId="EBI-73886">
<id>Q04206</id>
<label>RELA</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-5240785">
<id>Q8IXJ6-2</id>
</interactant>
<interactant intactId="EBI-367462">
<id>Q12834</id>
<label>CDC20</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="interaction">
<interactant intactId="EBI-5240785">
<id>Q8IXJ6-2</id>
</interactant>
<interactant intactId="EBI-724997">
<id>Q9UM11</id>
<label>FZR1</label>
</interactant>
<organismsDiffer>false</organismsDiffer>
<experiments>2</experiments>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location>Nucleus</location>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasm</location>
<location>Perinuclear region</location>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasm</location>
<location>Cytoskeleton</location>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasm</location>
<location>Cytoskeleton</location>
<location>Microtubule organizing center</location>
<location>Centrosome</location>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasm</location>
<location>Cytoskeleton</location>
<location>Microtubule organizing center</location>
<location>Centrosome</location>
<location>Centriole</location>
</subcellularLocation>
<subcellularLocation>
<location>Cytoplasm</location>
<location>Cytoskeleton</location>
<location>Spindle</location>
</subcellularLocation>
<subcellularLocation>
<location>Midbody</location>
</subcellularLocation>
<subcellularLocation>
<location>Chromosome</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="13">Perikaryon</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="13">Cell projection</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="13">Cell projection</location>
<location evidence="13">Growth cone</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="13">Myelin membrane</location>
</subcellularLocation>
<text evidence="13">Deacetylates FOXO3 in the cytoplasm. Colocalizes with PLP1 in internodal regions, at paranodal axoglial junction and Schmidt-Lanterman incisures of myelin sheat. Colocalizes with CDK5R1 in the perikaryon, neurites and growth cone of hippocampal neurons. Colocalizes with alpha-tubulin in neuronal growth cone. Localizes in the cytoplasm and nucleus of germinal vesicle (GV) stage oocytes. Colocalizes with alpha-tubulin on the meiotic spindle as the oocytes enter into metaphase, and also during meiotic anaphase and telophase, especially with the midbody. Colocalizes with PARD3 in internodal region of axons. Colocalizes with acetylated alpha-tubulin in cell projection processes during primary oligodendrocyte precursor (OLP) differentiation (By similarity). Localizes in the cytoplasm during most of the cell cycle except in the G2/M transition and during mitosis, where it is localized in association with chromatin and induces deacetylation of histone at 'Lys-16' (H4K16ac). Colocalizes with KMT5A at mitotic foci. Colocalizes with CDK1 at centrosome during prophase and splindle fibers during metaphase. Colocalizes with Aurora kinase AURKA at centrosome during early prophase and in the centrioles and growing mitotic spindle throughout metaphase. Colocalizes with Aurora kinase AURKB during cytokinesis with the midbody. Colocalizes with microtubules. Detected in perinuclear foci that may be aggresomes containing misfolded, ubiquitinated proteins. Shuttles between the cytoplasm and the nucleus through the CRM1 export pathway. Colocalizes with EP300 in the nucleus. Translocates to the nucleus and chromatin upon bacterium Listeria monocytogenes infection in interphase cells.</text>
</comment>
<comment type="subcellular location">
<molecule>Isoform 1</molecule>
<subcellularLocation>
<location evidence="52">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="52">Nucleus</location>
</subcellularLocation>
<text>Predominantly localized in the cytoplasmic.</text>
</comment>
<comment type="subcellular location">
<molecule>Isoform 2</molecule>
<subcellularLocation>
<location evidence="52">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="52">Nucleus</location>
</subcellularLocation>
<text>Predominantly localized in the cytoplasmic.</text>
</comment>
<comment type="subcellular location">
<molecule>Isoform 5</molecule>
<subcellularLocation>
<location evidence="52">Cytoplasm</location>
</subcellularLocation>
<subcellularLocation>
<location evidence="52">Nucleus</location>
</subcellularLocation>
<text>Predominantly localized in the nucleus.</text>
</comment>
<comment type="alternative products">
<event type="alternative splicing"/>
<isoform>
<id>Q8IXJ6-1</id>
<name>1</name>
<sequence type="displayed"/>
</isoform>
<isoform>
<id>Q8IXJ6-2</id>
<name>2</name>
<sequence type="described" ref="VSP_008724"/>
</isoform>
<isoform>
<id>Q8IXJ6-3</id>
<name>3</name>
<sequence type="described" ref="VSP_008726"/>
</isoform>
<isoform>
<id>Q8IXJ6-4</id>
<name>4</name>
<sequence type="described" ref="VSP_008727 VSP_008728"/>
</isoform>
<isoform>
<id>Q8IXJ6-5</id>
<name>5</name>
<sequence type="described" ref="VSP_055328"/>
</isoform>
</comment>
<comment type="tissue specificity">
<text evidence="17 18 24 27 42 44">Isoform 1 is expressed in heart, liver and skeletal muscle, weakly expressed in the cortex. Isoform 2 is strongly expressed in the cortex, weakly expressed in heart and liver. Weakly expressed in several malignancies including breast, liver, brain, kidney and prostate cancers compared to normal tissues. Weakly expressed in glioma cell lines compared to normal brain tissues (at protein level). Widely expressed. Highly expressed in heart, brain and skeletal muscle, while it is weakly expressed in placenta and lung. Down-regulated in many gliomas suggesting that it may act as a tumor suppressor gene in human gliomas possibly through the regulation of microtubule network.</text>
</comment>
<comment type="developmental stage">
<text evidence="23">Peaks during mitosis. After mitosis, it is probably degraded by the 26S proteasome.</text>
</comment>
<comment type="induction">
<text evidence="27 34 41">Up-regulated in response to low levels of glucose and anoxia-reoxygenation stress. Up-regulated by trichostatin A. Down-regulated in response to high levels of glucose. Down-regulated by histone deacetylation in several tumors.</text>
</comment>
<comment type="PTM">
<text evidence="23 28 29 33">Phosphorylated at phosphoserine and phosphothreonine. Phosphorylated at Ser-368 by a mitotic kinase CDK1/cyclin B at the G2/M transition; phosphorylation regulates the delay in cell-cycle progression. Phosphorylated at Ser-368 by a mitotic kinase G1/S-specific cyclin E/Cdk2 complex; phosphorylation inactivates SIRT2-mediated alpha-tubulin deacetylation and thereby negatively regulates cell adhesion, cell migration and neurite outgrowth during neuronal differentiation. Phosphorylated by cyclin A/Cdk2 and p35-Cdk5 complexes and to a lesser extent by the cyclin D3/Cdk4 and cyclin B/Cdk1, in vitro. Dephosphorylated at Ser-368 by CDC14A and CDC14B around early anaphase.</text>
</comment>
<comment type="PTM">
<text evidence="35">Acetylated by EP300; acetylation leads both to the decreased of SIRT2-mediated alpha-tubulin deacetylase activity and SIRT2-mediated down-regulation of TP53 transcriptional activity.</text>
</comment>
<comment type="PTM">
<text evidence="23 29">Ubiquitinated.</text>
</comment>
<comment type="miscellaneous">
<molecule>Isoform 5</molecule>
<text evidence="67">Lacks deacetylase activity, at least toward known SIRT2 targets.</text>
</comment>
<comment type="similarity">
<text evidence="67">Belongs to the sirtuin family. Class I subfamily.</text>
</comment>
<comment type="sequence caution" evidence="67">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="AAD45971" version="1"/>
</conflict>
</comment>
<comment type="sequence caution" evidence="67">
<conflict type="frameshift">
<sequence resource="EMBL-CDS" id="AAF67015" version="1"/>
</conflict>
</comment>
<dbReference type="EC" id="2.3.1.286" evidence="20 21 26 35 52 56 57"/>
<dbReference type="EMBL" id="AF083107">
<property type="protein sequence ID" value="AAD40850.2"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF095714">
<property type="protein sequence ID" value="AAD45971.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY030277">
<property type="protein sequence ID" value="AAK51133.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="KF032391">
<property type="protein sequence ID" value="AGZ02589.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AJ505014">
<property type="protein sequence ID" value="CAD43717.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF160214">
<property type="protein sequence ID" value="AAF67015.1"/>
<property type="status" value="ALT_FRAME"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK290716">
<property type="protein sequence ID" value="BAF83405.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AK314492">
<property type="protein sequence ID" value="BAG37092.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471126">
<property type="protein sequence ID" value="EAW56833.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="CH471126">
<property type="protein sequence ID" value="EAW56835.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC003012">
<property type="protein sequence ID" value="AAH03012.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC003547">
<property type="protein sequence ID" value="AAH03547.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF131800">
<property type="protein sequence ID" value="AAD20046.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS12523.1">
<molecule id="Q8IXJ6-1"/>
</dbReference>
<dbReference type="CCDS" id="CCDS46069.1">
<molecule id="Q8IXJ6-2"/>
</dbReference>
<dbReference type="RefSeq" id="NP_001180215.1">
<property type="nucleotide sequence ID" value="NM_001193286.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_036369.2">
<molecule id="Q8IXJ6-1"/>
<property type="nucleotide sequence ID" value="NM_012237.3"/>
</dbReference>
<dbReference type="RefSeq" id="NP_085096.1">
<molecule id="Q8IXJ6-2"/>
<property type="nucleotide sequence ID" value="NM_030593.2"/>
</dbReference>
<dbReference type="RefSeq" id="XP_006723174.1">
<molecule id="Q8IXJ6-2"/>
<property type="nucleotide sequence ID" value="XM_006723111.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011524956.1">
<molecule id="Q8IXJ6-2"/>
<property type="nucleotide sequence ID" value="XM_011526654.1"/>
</dbReference>
<dbReference type="RefSeq" id="XP_011524957.1">
<molecule id="Q8IXJ6-5"/>
<property type="nucleotide sequence ID" value="XM_011526655.1"/>
</dbReference>
<dbReference type="PDB" id="1J8F">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.70"/>
<property type="chains" value="A/B/C=34-356"/>
</dbReference>
<dbReference type="PDB" id="3ZGO">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.63"/>
<property type="chains" value="A/B/C=34-356"/>
</dbReference>
<dbReference type="PDB" id="3ZGV">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.27"/>
<property type="chains" value="A/B=34-356"/>
</dbReference>
<dbReference type="PDB" id="4L3O">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.52"/>
<property type="chains" value="A/B/C/D=55-356"/>
</dbReference>
<dbReference type="PDB" id="4R8M">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A/B=38-356"/>
</dbReference>
<dbReference type="PDB" id="4RMG">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.88"/>
<property type="chains" value="A=56-356"/>
</dbReference>
<dbReference type="PDB" id="4RMH">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.42"/>
<property type="chains" value="A=56-356"/>
</dbReference>
<dbReference type="PDB" id="4RMI">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.45"/>
<property type="chains" value="A=56-356"/>
</dbReference>
<dbReference type="PDB" id="4RMJ">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.87"/>
<property type="chains" value="A/B=56-356"/>
</dbReference>
<dbReference type="PDB" id="4X3O">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.50"/>
<property type="chains" value="A=52-355"/>
</dbReference>
<dbReference type="PDB" id="4X3P">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.80"/>
<property type="chains" value="A=52-355"/>
</dbReference>
<dbReference type="PDB" id="4Y6L">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.60"/>
<property type="chains" value="A/B=52-356"/>
</dbReference>
<dbReference type="PDB" id="4Y6O">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.60"/>
<property type="chains" value="A/B=52-356"/>
</dbReference>
<dbReference type="PDB" id="4Y6Q">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.90"/>
<property type="chains" value="A/B/C/D=52-356"/>
</dbReference>
<dbReference type="PDB" id="5D7O">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.63"/>
<property type="chains" value="A/B=50-356"/>
</dbReference>
<dbReference type="PDB" id="5D7P">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.76"/>
<property type="chains" value="A/B=56-356"/>
</dbReference>
<dbReference type="PDB" id="5D7Q">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.01"/>
<property type="chains" value="A/B=56-356"/>
</dbReference>
<dbReference type="PDB" id="5DY4">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.77"/>
<property type="chains" value="A=56-356"/>
</dbReference>
<dbReference type="PDB" id="5DY5">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.95"/>
<property type="chains" value="A=56-356"/>
</dbReference>
<dbReference type="PDB" id="5FYQ">
<property type="method" value="X-ray"/>
<property type="resolution" value="3.00"/>
<property type="chains" value="A/B=1-356"/>
</dbReference>
<dbReference type="PDB" id="5G4C">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.10"/>
<property type="chains" value="A/B=34-356"/>
</dbReference>
<dbReference type="PDB" id="5MAR">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.89"/>
<property type="chains" value="A/B=56-356"/>
</dbReference>
<dbReference type="PDB" id="5MAT">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.07"/>
<property type="chains" value="A/C=56-356"/>
</dbReference>
<dbReference type="PDB" id="5Y0Z">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.00"/>
<property type="chains" value="A/B=52-356"/>
</dbReference>
<dbReference type="PDB" id="5Y5N">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.30"/>
<property type="chains" value="A=32-356"/>
</dbReference>
<dbReference type="PDB" id="5YQL">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.60"/>
<property type="chains" value="A=56-356"/>
</dbReference>
<dbReference type="PDB" id="5YQM">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.74"/>
<property type="chains" value="A=56-356"/>
</dbReference>
<dbReference type="PDB" id="5YQN">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.60"/>
<property type="chains" value="A=56-356"/>
</dbReference>
<dbReference type="PDB" id="5YQO">
<property type="method" value="X-ray"/>
<property type="resolution" value="1.48"/>
<property type="chains" value="A=56-356"/>
</dbReference>
<dbReference type="PDB" id="6NR0">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.45"/>
<property type="chains" value="A/B=38-356"/>
</dbReference>
<dbReference type="PDB" id="6QCN">
<property type="method" value="X-ray"/>
<property type="resolution" value="2.23"/>
<property type="chains" value="A/B=55-356"/>
</dbReference>
<dbReference type="PDBsum" id="1J8F"/>
<dbReference type="PDBsum" id="3ZGO"/>
<dbReference type="PDBsum" id="3ZGV"/>
<dbReference type="PDBsum" id="4L3O"/>
<dbReference type="PDBsum" id="4R8M"/>
<dbReference type="PDBsum" id="4RMG"/>
<dbReference type="PDBsum" id="4RMH"/>
<dbReference type="PDBsum" id="4RMI"/>
<dbReference type="PDBsum" id="4RMJ"/>
<dbReference type="PDBsum" id="4X3O"/>
<dbReference type="PDBsum" id="4X3P"/>
<dbReference type="PDBsum" id="4Y6L"/>
<dbReference type="PDBsum" id="4Y6O"/>
<dbReference type="PDBsum" id="4Y6Q"/>
<dbReference type="PDBsum" id="5D7O"/>
<dbReference type="PDBsum" id="5D7P"/>
<dbReference type="PDBsum" id="5D7Q"/>
<dbReference type="PDBsum" id="5DY4"/>
<dbReference type="PDBsum" id="5DY5"/>
<dbReference type="PDBsum" id="5FYQ"/>
<dbReference type="PDBsum" id="5G4C"/>
<dbReference type="PDBsum" id="5MAR"/>
<dbReference type="PDBsum" id="5MAT"/>
<dbReference type="PDBsum" id="5Y0Z"/>
<dbReference type="PDBsum" id="5Y5N"/>
<dbReference type="PDBsum" id="5YQL"/>
<dbReference type="PDBsum" id="5YQM"/>
<dbReference type="PDBsum" id="5YQN"/>
<dbReference type="PDBsum" id="5YQO"/>
<dbReference type="PDBsum" id="6NR0"/>
<dbReference type="PDBsum" id="6QCN"/>
<dbReference type="SMR" id="Q8IXJ6"/>
<dbReference type="BioGRID" id="116593">
<property type="interactions" value="71"/>
</dbReference>
<dbReference type="DIP" id="DIP-33350N"/>
<dbReference type="IntAct" id="Q8IXJ6">
<property type="interactions" value="46"/>
</dbReference>
<dbReference type="MINT" id="Q8IXJ6"/>
<dbReference type="STRING" id="9606.ENSP00000249396"/>
<dbReference type="ChEMBL" id="CHEMBL4462"/>
<dbReference type="DrugBank" id="DB15493">
<property type="generic name" value="Cambinol"/>
</dbReference>
<dbReference type="DrugCentral" id="Q8IXJ6"/>
<dbReference type="GuidetoPHARMACOLOGY" id="2708"/>
<dbReference type="iPTMnet" id="Q8IXJ6"/>
<dbReference type="PhosphoSitePlus" id="Q8IXJ6"/>
<dbReference type="BioMuta" id="SIRT2"/>
<dbReference type="DMDM" id="38258608"/>
<dbReference type="EPD" id="Q8IXJ6"/>
<dbReference type="jPOST" id="Q8IXJ6"/>
<dbReference type="MassIVE" id="Q8IXJ6"/>
<dbReference type="MaxQB" id="Q8IXJ6"/>
<dbReference type="PaxDb" id="Q8IXJ6"/>
<dbReference type="PeptideAtlas" id="Q8IXJ6"/>
<dbReference type="PRIDE" id="Q8IXJ6"/>
<dbReference type="ProteomicsDB" id="71008">
<molecule id="Q8IXJ6-1"/>
</dbReference>
<dbReference type="ProteomicsDB" id="71009">
<molecule id="Q8IXJ6-2"/>
</dbReference>
<dbReference type="ProteomicsDB" id="71010">
<molecule id="Q8IXJ6-3"/>
</dbReference>
<dbReference type="ProteomicsDB" id="71011">
<molecule id="Q8IXJ6-4"/>
</dbReference>
<dbReference type="Antibodypedia" id="2167">
<property type="antibodies" value="548 antibodies"/>
</dbReference>
<dbReference type="DNASU" id="22933"/>
<dbReference type="Ensembl" id="ENST00000249396">
<molecule id="Q8IXJ6-1"/>
<property type="protein sequence ID" value="ENSP00000249396"/>
<property type="gene ID" value="ENSG00000068903"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000392081">
<molecule id="Q8IXJ6-2"/>
<property type="protein sequence ID" value="ENSP00000375931"/>
<property type="gene ID" value="ENSG00000068903"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000634533">
<molecule id="Q8IXJ6-1"/>
<property type="protein sequence ID" value="ENSP00000489602"/>
<property type="gene ID" value="ENSG00000283100"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000635478">
<molecule id="Q8IXJ6-2"/>
<property type="protein sequence ID" value="ENSP00000488940"/>
<property type="gene ID" value="ENSG00000283100"/>
</dbReference>
<dbReference type="GeneID" id="22933"/>
<dbReference type="KEGG" id="hsa:22933"/>
<dbReference type="UCSC" id="uc002ojt.3">
<molecule id="Q8IXJ6-1"/>
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="22933"/>
<dbReference type="DisGeNET" id="22933"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000068903.19"/>
<dbReference type="GeneCards" id="SIRT2"/>
<dbReference type="HGNC" id="HGNC:10886">
<property type="gene designation" value="SIRT2"/>
</dbReference>
<dbReference type="HPA" id="ENSG00000068903">
<property type="expression patterns" value="Tissue enhanced (brain, skeletal muscle)"/>
</dbReference>
<dbReference type="MIM" id="604480">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q8IXJ6"/>
<dbReference type="OpenTargets" id="ENSG00000068903"/>
<dbReference type="PharmGKB" id="PA35786"/>
<dbReference type="eggNOG" id="KOG2682">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00940000157514"/>
<dbReference type="HOGENOM" id="CLU_023643_7_4_1"/>
<dbReference type="InParanoid" id="Q8IXJ6"/>
<dbReference type="KO" id="K11412"/>
<dbReference type="OrthoDB" id="973532at2759"/>
<dbReference type="PhylomeDB" id="Q8IXJ6"/>
<dbReference type="TreeFam" id="TF106181"/>
<dbReference type="PathwayCommons" id="Q8IXJ6"/>
<dbReference type="Reactome" id="R-HSA-2995383">
<property type="pathway name" value="Initiation of Nuclear Envelope (NE) Reformation"/>
</dbReference>
<dbReference type="SABIO-RK" id="Q8IXJ6"/>
<dbReference type="SIGNOR" id="Q8IXJ6"/>
<dbReference type="BioGRID-ORCS" id="22933">
<property type="hits" value="7 hits in 876 CRISPR screens"/>
</dbReference>
<dbReference type="ChiTaRS" id="SIRT2">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="EvolutionaryTrace" id="Q8IXJ6"/>
<dbReference type="GeneWiki" id="SIRT2"/>
<dbReference type="GenomeRNAi" id="22933"/>
<dbReference type="Pharos" id="Q8IXJ6">
<property type="development level" value="Tchem"/>
</dbReference>
<dbReference type="PRO" id="PR:Q8IXJ6"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 19"/>
</dbReference>
<dbReference type="RNAct" id="Q8IXJ6">
<property type="molecule type" value="protein"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000068903">
<property type="expression patterns" value="Expressed in C1 segment of cervical spinal cord and 242 other tissues"/>
</dbReference>
<dbReference type="ExpressionAtlas" id="Q8IXJ6">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q8IXJ6">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0005814">
<property type="term" value="C:centriole"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005813">
<property type="term" value="C:centrosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005677">
<property type="term" value="C:chromatin silencing complex"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005694">
<property type="term" value="C:chromosome"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000781">
<property type="term" value="C:chromosome, telomeric region"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="GOC"/>
</dbReference>
<dbReference type="GO" id="GO:0005737">
<property type="term" value="C:cytoplasm"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005829">
<property type="term" value="C:cytosol"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0097386">
<property type="term" value="C:glial cell projection"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030426">
<property type="term" value="C:growth cone"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-SubCell"/>
</dbReference>
<dbReference type="GO" id="GO:0044224">
<property type="term" value="C:juxtaparanode region of axon"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043219">
<property type="term" value="C:lateral loop"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0072687">
<property type="term" value="C:meiotic spindle"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005874">
<property type="term" value="C:microtubule"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0030496">
<property type="term" value="C:midbody"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005739">
<property type="term" value="C:mitochondrion"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0072686">
<property type="term" value="C:mitotic spindle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043209">
<property type="term" value="C:myelin sheath"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005720">
<property type="term" value="C:nuclear heterochromatin"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005730">
<property type="term" value="C:nucleolus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0005634">
<property type="term" value="C:nucleus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0033010">
<property type="term" value="C:paranodal junction"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0033270">
<property type="term" value="C:paranode region of axon"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043204">
<property type="term" value="C:perikaryon"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048471">
<property type="term" value="C:perinuclear region of cytoplasm"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005886">
<property type="term" value="C:plasma membrane"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="HPA"/>
</dbReference>
<dbReference type="GO" id="GO:0043220">
<property type="term" value="C:Schmidt-Lanterman incisure"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005819">
<property type="term" value="C:spindle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003682">
<property type="term" value="F:chromatin binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035035">
<property type="term" value="F:histone acetyltransferase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0004407">
<property type="term" value="F:histone deacetylase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042826">
<property type="term" value="F:histone deacetylase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0003950">
<property type="term" value="F:NAD+ ADP-ribosyltransferase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0070403">
<property type="term" value="F:NAD+ binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0017136">
<property type="term" value="F:NAD-dependent histone deacetylase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0046970">
<property type="term" value="F:NAD-dependent histone deacetylase activity (H4-K16 specific)"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034979">
<property type="term" value="F:NAD-dependent protein deacetylase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0033558">
<property type="term" value="F:protein deacetylase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008134">
<property type="term" value="F:transcription factor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042903">
<property type="term" value="F:tubulin deacetylase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043130">
<property type="term" value="F:ubiquitin binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008270">
<property type="term" value="F:zinc ion binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006914">
<property type="term" value="P:autophagy"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0051301">
<property type="term" value="P:cell division"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0044242">
<property type="term" value="P:cellular lipid catabolic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0061433">
<property type="term" value="P:cellular response to caloric restriction"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071872">
<property type="term" value="P:cellular response to epinephrine stimulus"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0035729">
<property type="term" value="P:cellular response to hepatocyte growth factor stimulus"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071456">
<property type="term" value="P:cellular response to hypoxia"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0071219">
<property type="term" value="P:cellular response to molecule of bacterial origin"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034599">
<property type="term" value="P:cellular response to oxidative stress"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006342">
<property type="term" value="P:chromatin silencing"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006348">
<property type="term" value="P:chromatin silencing at telomere"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0048012">
<property type="term" value="P:hepatocyte growth factor receptor signaling pathway"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0016575">
<property type="term" value="P:histone deacetylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070932">
<property type="term" value="P:histone H3 deacetylation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0070933">
<property type="term" value="P:histone H4 deacetylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045087">
<property type="term" value="P:innate immune response"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0051321">
<property type="term" value="P:meiotic cell cycle"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="UniProtKB-KW"/>
</dbReference>
<dbReference type="GO" id="GO:0022011">
<property type="term" value="P:myelination in peripheral nervous system"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010507">
<property type="term" value="P:negative regulation of autophagy"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0008285">
<property type="term" value="P:negative regulation of cell population proliferation"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1900425">
<property type="term" value="P:negative regulation of defense response to bacterium"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045599">
<property type="term" value="P:negative regulation of fat cell differentiation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1900226">
<property type="term" value="P:negative regulation of NLRP3 inflammasome complex assembly"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="GO" id="GO:0070446">
<property type="term" value="P:negative regulation of oligodendrocyte progenitor proliferation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0010801">
<property type="term" value="P:negative regulation of peptidyl-threonine phosphorylation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042177">
<property type="term" value="P:negative regulation of protein catabolic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000378">
<property type="term" value="P:negative regulation of reactive oxygen species metabolic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045843">
<property type="term" value="P:negative regulation of striated muscle tissue development"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000122">
<property type="term" value="P:negative regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0061428">
<property type="term" value="P:negative regulation of transcription from RNA polymerase II promoter in response to hypoxia"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045892">
<property type="term" value="P:negative regulation of transcription, DNA-templated"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0034983">
<property type="term" value="P:peptidyl-lysine deacetylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0014065">
<property type="term" value="P:phosphatidylinositol 3-kinase signaling"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051987">
<property type="term" value="P:positive regulation of attachment of spindle microtubules to kinetochore"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051781">
<property type="term" value="P:positive regulation of cell division"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043388">
<property type="term" value="P:positive regulation of DNA binding"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1900119">
<property type="term" value="P:positive regulation of execution phase of apoptosis"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045836">
<property type="term" value="P:positive regulation of meiotic nuclear division"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:1900195">
<property type="term" value="P:positive regulation of oocyte maturation"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0032436">
<property type="term" value="P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:2000777">
<property type="term" value="P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process involved in cellular response to hypoxia"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0045944">
<property type="term" value="P:positive regulation of transcription by RNA polymerase II"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043161">
<property type="term" value="P:proteasome-mediated ubiquitin-dependent protein catabolic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0006471">
<property type="term" value="P:protein ADP-ribosylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0006476">
<property type="term" value="P:protein deacetylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0043491">
<property type="term" value="P:protein kinase B signaling"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0000183">
<property type="term" value="P:rDNA heterochromatin assembly"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051726">
<property type="term" value="P:regulation of cell cycle"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0007096">
<property type="term" value="P:regulation of exit from mitosis"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0031641">
<property type="term" value="P:regulation of myelination"/>
<property type="evidence" value="ECO:0000250"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0042325">
<property type="term" value="P:regulation of phosphorylation"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0051775">
<property type="term" value="P:response to redox state"/>
<property type="evidence" value="ECO:0000303"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0021762">
<property type="term" value="P:substantia nigra development"/>
<property type="evidence" value="ECO:0007007"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0090042">
<property type="term" value="P:tubulin deacetylation"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="Gene3D" id="3.30.1600.10">
<property type="match status" value="1"/>
</dbReference>
<dbReference type="InterPro" id="IPR029035">
<property type="entry name" value="DHS-like_NAD/FAD-binding_dom"/>
</dbReference>
<dbReference type="InterPro" id="IPR003000">
<property type="entry name" value="Sirtuin"/>
</dbReference>
<dbReference type="InterPro" id="IPR026591">
<property type="entry name" value="Sirtuin_cat_small_dom_sf"/>
</dbReference>
<dbReference type="InterPro" id="IPR017328">
<property type="entry name" value="Sirtuin_class_I"/>
</dbReference>
<dbReference type="InterPro" id="IPR026590">
<property type="entry name" value="Ssirtuin_cat_dom"/>
</dbReference>
<dbReference type="Pfam" id="PF02146">
<property type="entry name" value="SIR2"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PIRSF" id="PIRSF037938">
<property type="entry name" value="SIR2_euk"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="SUPFAM" id="SSF52467">
<property type="entry name" value="SSF52467"/>
<property type="match status" value="1"/>
</dbReference>
<dbReference type="PROSITE" id="PS50305">
<property type="entry name" value="SIRTUIN"/>
<property type="match status" value="1"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0002">3D-structure</keyword>
<keyword id="KW-0007">Acetylation</keyword>
<keyword id="KW-0025">Alternative splicing</keyword>
<keyword id="KW-0072">Autophagy</keyword>
<keyword id="KW-0131">Cell cycle</keyword>
<keyword id="KW-0132">Cell division</keyword>
<keyword id="KW-1003">Cell membrane</keyword>
<keyword id="KW-0966">Cell projection</keyword>
<keyword id="KW-0158">Chromosome</keyword>
<keyword id="KW-0963">Cytoplasm</keyword>
<keyword id="KW-0206">Cytoskeleton</keyword>
<keyword id="KW-0221">Differentiation</keyword>
<keyword id="KW-0391">Immunity</keyword>
<keyword id="KW-0399">Innate immunity</keyword>
<keyword id="KW-0469">Meiosis</keyword>
<keyword id="KW-0472">Membrane</keyword>
<keyword id="KW-0479">Metal-binding</keyword>
<keyword id="KW-0493">Microtubule</keyword>
<keyword id="KW-0498">Mitosis</keyword>
<keyword id="KW-0520">NAD</keyword>
<keyword id="KW-0523">Neurodegeneration</keyword>
<keyword id="KW-0524">Neurogenesis</keyword>
<keyword id="KW-0539">Nucleus</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0804">Transcription</keyword>
<keyword id="KW-0805">Transcription regulation</keyword>
<keyword id="KW-0808">Transferase</keyword>
<keyword id="KW-0832">Ubl conjugation</keyword>
<keyword id="KW-0862">Zinc</keyword>
<feature type="initiator methionine" description="Removed" evidence="10">
<location>
<position position="1"/>
</location>
</feature>
<feature type="chain" description="NAD-dependent protein deacetylase sirtuin-2" id="PRO_0000110258">
<location>
<begin position="2"/>
<end position="389"/>
</location>
</feature>
<feature type="domain" description="Deacetylase sirtuin-type" evidence="16">
<location>
<begin position="65"/>
<end position="340"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="NAD" evidence="3 57">
<location>
<begin position="85"/>
<end position="89"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="NAD" evidence="3 57">
<location>
<begin position="95"/>
<end position="97"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="NAD" evidence="3 57">
<location>
<begin position="167"/>
<end position="170"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="NAD" evidence="3 57">
<location>
<begin position="262"/>
<end position="263"/>
</location>
</feature>
<feature type="nucleotide phosphate-binding region" description="NAD" evidence="3 57">
<location>
<begin position="286"/>
<end position="288"/>
</location>
</feature>
<feature type="region of interest" description="Peptide inhibitor binding">
<location>
<begin position="116"/>
<end position="120"/>
</location>
</feature>
<feature type="region of interest" description="Peptide inhibitor binding">
<location>
<begin position="232"/>
<end position="301"/>
</location>
</feature>
<feature type="short sequence motif" description="Nuclear export signal">
<location>
<begin position="41"/>
<end position="51"/>
</location>
</feature>
<feature type="active site" description="Proton acceptor" evidence="67">
<location>
<position position="187"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc" evidence="16 19 47 53 57">
<location>
<position position="195"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc" evidence="16 19 47 53 57">
<location>
<position position="200"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc" evidence="16 19 47 53 57">
<location>
<position position="221"/>
</location>
</feature>
<feature type="metal ion-binding site" description="Zinc" evidence="16 19 47 53 57">
<location>
<position position="224"/>
</location>
</feature>
<feature type="binding site" description="NAD; via amide nitrogen" evidence="3 57">
<location>
<position position="324"/>
</location>
</feature>
<feature type="modified residue" description="N-acetylalanine" evidence="10">
<location>
<position position="2"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="12">
<location>
<position position="23"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="12">
<location>
<position position="25"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="12">
<location>
<position position="27"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="14">
<location>
<position position="53"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="14">
<location>
<position position="100"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="14">
<location>
<position position="207"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine; by CDK2 and CDK5" evidence="11 28 29 33">
<location>
<position position="368"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="29">
<location>
<position position="372"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 3." id="VSP_008726" evidence="66">
<original>MAEPDPSHPLETQAGKVQEAQDSDSDSEGGAAGGEADM</original>
<variation>MPLAECPSCRCLSSFRSV</variation>
<location>
<begin position="1"/>
<end position="38"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 2." id="VSP_008724" evidence="59 60 61 62 63">
<location>
<begin position="1"/>
<end position="37"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 5." id="VSP_055328" evidence="64">
<original>PSHPLETQAGKVQEAQDSDSDSEGGAAGGEADMDFLRNLFSQTLSLGSQKERLLDELTLEGVARYMQSERC</original>
<variation>R</variation>
<location>
<begin position="6"/>
<end position="76"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_008727" evidence="65">
<original>VQPFAS</original>
<variation>GRGLAG</variation>
<location>
<begin position="266"/>
<end position="271"/>
</location>
</feature>
<feature type="splice variant" description="In isoform 4." id="VSP_008728" evidence="65">
<location>
<begin position="272"/>
<end position="389"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces deacetylase activity." evidence="29">
<original>S</original>
<variation>A</variation>
<location>
<position position="53"/>
</location>
</feature>
<feature type="mutagenesis site" description="No effect on deacetylase activity." evidence="19">
<original>R</original>
<variation>A</variation>
<location>
<position position="97"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inhibits deacetylase activity." evidence="29">
<original>S</original>
<variation>A</variation>
<location>
<position position="98"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces deacetylase activity." evidence="29">
<original>S</original>
<variation>A</variation>
<location>
<position position="100"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces binding for the peptide inhibitor S2iL5." evidence="53">
<original>E</original>
<variation>A</variation>
<location>
<position position="116"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces binding for the peptide inhibitor S2iL5." evidence="53">
<original>E</original>
<variation>A</variation>
<location>
<position position="120"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces deacetylase activity. Inhibits the block of entry to chromosome condensation and subsequent hyperploidy cell formation in response to mitotic stress; when associated with A-168 and A-187." evidence="19 27">
<original>Q</original>
<variation>A</variation>
<location>
<position position="167"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes deacetylation of alpha-tubulin. Inhibits deacetylation of histone H3 at 'Lys-18'. Inhibits the block of entry to chromosome condensation and subsequent hyperploidy cell formation in response to mitotic stress; when associated with A-167 and A-187." evidence="19 22 27 50 55">
<original>N</original>
<variation>A</variation>
<location>
<position position="168"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces deacetylase activity." evidence="19">
<original>D</original>
<variation>A</variation>
<variation>N</variation>
<location>
<position position="170"/>
</location>
</feature>
<feature type="mutagenesis site" description="Inhibits deacetylase activity toward histone, alpha-tubulin, FZR1 and CDC20. No effect on CDK2-dependent phosphorylation. Does not inhibit interaction with alpha-tubulin, HDAC6, HIF1A and the cyclin E-CDK2 complex. Inhibits interaction with BEX4 and KMT5A. Abolishes deacetylation, dimeric formation and enzymatic activity increase of G6PD. Prevents histone H4 methylation at 'Lys-20'(H4K20me1) in metaphase chromosomes. Inhibits the block of entry to chromosome condensation and subsequent hyperploidy cell formation in response to mitotic stress; when associated with A-167 and A-168." evidence="17 19 21 22 23 27 28 29 31 44 54 58">
<original>H</original>
<variation>Y</variation>
<variation>A</variation>
<location>
<position position="187"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces strongly binding for the peptide inhibitor S2iL5." evidence="53">
<original>F</original>
<variation>A</variation>
<location>
<position position="244"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces binding for the peptide inhibitor S2iL5." evidence="53">
<original>Q</original>
<variation>A</variation>
<location>
<position position="265"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces binding for the peptide inhibitor S2iL5." evidence="53">
<original>S</original>
<variation>A</variation>
<location>
<position position="271"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces deacetylase activity." evidence="29">
<original>S</original>
<variation>A</variation>
<location>
<position position="279"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces deacetylase activity." evidence="29">
<original>T</original>
<variation>A</variation>
<location>
<position position="280"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces binding for the peptide inhibitor S2iL5." evidence="53">
<original>D</original>
<variation>A</variation>
<location>
<position position="294"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces deacetylase activity." evidence="29">
<original>S</original>
<variation>A</variation>
<location>
<position position="311"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces deacetylase activity." evidence="29">
<original>Y</original>
<variation>A</variation>
<location>
<position position="315"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes CDK2-dependent phosphorylation." evidence="29">
<original>S</original>
<variation>A</variation>
<location>
<position position="364"/>
</location>
</feature>
<feature type="mutagenesis site" description="Does not affect deacetylase activity. Abolishes CDK2-dependent phosphorylation. Inhibits cellular proliferation delay in the early metaphase to prevent chromosomal instability. Does not inhibit interaction with a cyclin E-CDK2 complex. Does not inhibit interaction with HDAC6 and ubiquitination. Inhibits cell adhesion and migration and neurite outgrowth. Inhibits deacetylase activity; when associated with A-372." evidence="28 29 33">
<original>S</original>
<variation>A</variation>
<location>
<position position="368"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes CDK2-dependent phosphorylation. Inhibits interaction with a cyclin E-CDK2 complex. Reduces strongly histone deacetylation activity." evidence="28 29 33">
<original>S</original>
<variation>D</variation>
<location>
<position position="368"/>
</location>
</feature>
<feature type="mutagenesis site" description="Abolishes CDK2-dependent phosphorylation." evidence="28 29 33">
<original>S</original>
<variation>E</variation>
<location>
<position position="368"/>
</location>
</feature>
<feature type="mutagenesis site" description="Reduces phosphorylation. Does not inhibit interaction with HDAC6, ubiquitination and deacetylase activity. Inhibits deacetylase activity; when associated with A-368." evidence="29">
<original>S</original>
<variation>A</variation>
<location>
<position position="372"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 6." ref="6" evidence="67">
<original>S</original>
<variation>N</variation>
<location>
<position position="199"/>
</location>
</feature>
<feature type="sequence conflict" description="In Ref. 5; CAD43717." ref="5" evidence="67">
<original>P</original>
<variation>L</variation>
<location>
<position position="219"/>
</location>
</feature>
<feature type="helix" evidence="1">
<location>
<begin position="35"/>
<end position="45"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="60"/>
<end position="63"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="64"/>
<end position="71"/>
</location>
</feature>
<feature type="strand" evidence="2">
<location>
<begin position="73"/>
<end position="75"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="79"/>
<end position="83"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="85"/>
<end position="87"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="89"/>
<end position="91"/>
</location>
</feature>
<feature type="strand" evidence="5">
<location>
<begin position="96"/>
<end position="98"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="99"/>
<end position="101"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="103"/>
<end position="105"/>
</location>
</feature>
<feature type="helix" evidence="7">
<location>
<begin position="108"/>
<end position="110"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="115"/>
<end position="119"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="121"/>
<end position="126"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="129"/>
<end position="138"/>
</location>
</feature>
<feature type="strand" evidence="1">
<location>
<begin position="139"/>
<end position="142"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="147"/>
<end position="157"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="161"/>
<end position="166"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="172"/>
<end position="175"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="180"/>
<end position="182"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="183"/>
<end position="185"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="188"/>
<end position="196"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="198"/>
<end position="200"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="203"/>
<end position="205"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="206"/>
<end position="215"/>
</location>
</feature>
<feature type="turn" evidence="4">
<location>
<begin position="222"/>
<end position="224"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="227"/>
<end position="232"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="241"/>
<end position="250"/>
</location>
</feature>
<feature type="turn" evidence="5">
<location>
<begin position="251"/>
<end position="253"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="255"/>
<end position="261"/>
</location>
</feature>
<feature type="strand" evidence="9">
<location>
<begin position="264"/>
<end position="266"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="269"/>
<end position="275"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="282"/>
<end position="288"/>
</location>
</feature>
<feature type="turn" evidence="7">
<location>
<begin position="295"/>
<end position="297"/>
</location>
</feature>
<feature type="helix" evidence="8">
<location>
<begin position="301"/>
<end position="303"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="309"/>
<end position="311"/>
</location>
</feature>
<feature type="strand" evidence="4">
<location>
<begin position="316"/>
<end position="322"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="324"/>
<end position="334"/>
</location>
</feature>
<feature type="helix" evidence="4">
<location>
<begin position="338"/>
<end position="353"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3ZGO"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000244">
<source>
<dbReference type="PDB" id="3ZGV"/>
</source>
</evidence>
<evidence key="3" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4RMG"/>
</source>
</evidence>
<evidence key="4" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4RMH"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4RMI"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4RMJ"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000244">
<source>
<dbReference type="PDB" id="4X3O"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5DY4"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000244">
<source>
<dbReference type="PDB" id="5Y0Z"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="19413330"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="23186163"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000250"/>
<evidence key="14" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q5RJQ4"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000250">
<source>
<dbReference type="UniProtKB" id="Q8VDQ8"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000255">
<source>
<dbReference type="PROSITE-ProRule" id="PRU00236"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10381378"/>
</source>
</evidence>
<evidence key="18" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="10393250"/>
</source>
</evidence>
<evidence key="19" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11427894"/>
</source>
</evidence>
<evidence key="20" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11483616"/>
</source>
</evidence>
<evidence key="21" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11812793"/>
</source>
</evidence>
<evidence key="22" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12620231"/>
</source>
</evidence>
<evidence key="23" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12697818"/>
</source>
</evidence>
<evidence key="24" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12963026"/>
</source>
</evidence>
<evidence key="25" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15213244"/>
</source>
</evidence>
<evidence key="26" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16648462"/>
</source>
</evidence>
<evidence key="27" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16909107"/>
</source>
</evidence>
<evidence key="28" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17488717"/>
</source>
</evidence>
<evidence key="29" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17516032"/>
</source>
</evidence>
<evidence key="30" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17574768"/>
</source>
</evidence>
<evidence key="31" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17726514"/>
</source>
</evidence>
<evidence key="32" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18249187"/>
</source>
</evidence>
<evidence key="33" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18332217"/>
</source>
</evidence>
<evidence key="34" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18640115"/>
</source>
</evidence>
<evidence key="35" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18722353"/>
</source>
</evidence>
<evidence key="36" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="18995842"/>
</source>
</evidence>
<evidence key="37" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="19282667"/>
</source>
</evidence>
<evidence key="38" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20543840"/>
</source>
</evidence>
<evidence key="39" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="20587414"/>
</source>
</evidence>
<evidence key="40" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21081649"/>
</source>
</evidence>
<evidence key="41" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21726808"/>
</source>
</evidence>
<evidence key="42" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21791548"/>
</source>
</evidence>
<evidence key="43" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="21949390"/>
</source>
</evidence>
<evidence key="44" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22014574"/>
</source>
</evidence>
<evidence key="45" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22771473"/>
</source>
</evidence>
<evidence key="46" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="22819792"/>
</source>
</evidence>
<evidence key="47" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23454361"/>
</source>
</evidence>
<evidence key="48" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23468428"/>
</source>
</evidence>
<evidence key="49" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23806683"/>
</source>
</evidence>
<evidence key="50" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23908241"/>
</source>
</evidence>
<evidence key="51" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="23932781"/>
</source>
</evidence>
<evidence key="52" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24177535"/>
</source>
</evidence>
<evidence key="53" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24389023"/>
</source>
</evidence>
<evidence key="54" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24681946"/>
</source>
</evidence>
<evidence key="55" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24769394"/>
</source>
</evidence>
<evidence key="56" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="24940000"/>
</source>
</evidence>
<evidence key="57" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="25672491"/>
</source>
</evidence>
<evidence key="58" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="27512957"/>
</source>
</evidence>
<evidence key="59" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="10393250"/>
</source>
</evidence>
<evidence key="60" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="10931946"/>
</source>
</evidence>
<evidence key="61" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="12065666"/>
</source>
</evidence>
<evidence key="62" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="14702039"/>
</source>
</evidence>
<evidence key="63" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="15489334"/>
</source>
</evidence>
<evidence key="64" type="ECO:0000303">
<source>
<dbReference type="PubMed" id="24177535"/>
</source>
</evidence>
<evidence key="65" type="ECO:0000303">
<source ref="10"/>
</evidence>
<evidence key="66" type="ECO:0000303">
<source ref="5"/>
</evidence>
<evidence key="67" type="ECO:0000305"/>
<sequence length="389" mass="43182" checksum="A392442A8F6316F1" modified="2003-10-31" version="2">MAEPDPSHPLETQAGKVQEAQDSDSDSEGGAAGGEADMDFLRNLFSQTLSLGSQKERLLDELTLEGVARYMQSERCRRVICLVGAGISTSAGIPDFRSPSTGLYDNLEKYHLPYPEAIFEISYFKKHPEPFFALAKELYPGQFKPTICHYFMRLLKDKGLLLRCYTQNIDTLERIAGLEQEDLVEAHGTFYTSHCVSASCRHEYPLSWMKEKIFSEVTPKCEDCQSLVKPDIVFFGESLPARFFSCMQSDFLKVDLLLVMGTSLQVQPFASLISKAPLSTPRLLINKEKAGQSDPFLGMIMGLGGGMDFDSKKAYRDVAWLGECDQGCLALAELLGWKKELEDLVRREHASIDAQSGAGVPNPSTSASPKKSPPPAKDEARTTEREKPQ</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
Distributed under the Creative Commons Attribution (CC BY 4.0) License
</copyright>
</uniprot>

